O’Brien of Crohn’s and Colitis Canada · 2016-02-01 · Curriculum Vitae Gilaad G. Kaplan, MD,...

Curriculum Vitae Gilaad G. Kaplan, MD, MPH January 2016

1

Short Biosketch

Dr. Kaplan is a tenured Associate Professor in the Cumming School of Medicine at the

University of Calgary. Dr. Kaplan is a gastroenterologist and epidemiologist who has devoted his

clinical and research career to study the cause of gastrointestinal diseases, such as the

inflammatory bowel diseases (IBD), and improving the care of patients living with these

conditions. He graduated with a Masters of Public Health from the Harvard School of Public

Health and completed an IBD Fellowship at the Massachusetts General Hospital. He joined the

Faculty of Medicine at the University of Calgary in 2007 as a clinician-scientist with 80%

protected time for research. He was a Canadian Institutes for Health Research (CIHR) New

Investigator (2009-2014) and is an Alberta-Innovates Health-Solutions Population Health

Investigator (2010-2017). He is a member of the executive committee in the O’Brien Institute for

Public Health at the University of Calgary and the Scientific and Medical Advisory Committee

of Crohn’s and Colitis Canada. Dr. Kaplan was selected into the inaugural class of the AGA

Future Leaders Program. Dr. Kaplan has over 130 publications, with an H-index of 34 and over

4500 citations (source: Google Scholar). Dr. Kaplan’s study on the global epidemiology of IBD

(PMID: 22001864) is the most cited paper in Gastroenterology over the past 5 years with over

700 citations and a Field-Weighted Citation impact of 73.7 (source: Scopus). In the past 5 years

Dr. Kaplan has received nearly $6 million (total of 5 grants) from operating grants as the

principal investigator (PI) or co-PI, as well as over $16 million (total of 11 grants) as a co-

investigator. He is the PI on 3 successive operating grants from CIHR with uninterrupted funding

from 2008 to 2017. Dr. Kaplan distinctions include Avenue Magazine’s Calgary Top 40 Under

40 (2011), the Canadian Association of Gastroenterology Young Investigator Award (2013), and

the Killam Emerging Research Leader Award (2013). The overarching themes of his research

program are to study the environmental determinants (e.g. pollutants) that are associated with

gastrointestinal disorders and to improve the delivery of care to patients suffering from

gastrointestinal disease, such as IBD, through health service and population health research.

Dr. Kaplan’s research has been highlighted in international media:

Scientific American:

http://www.scientificamerican.com/article.cfm?id=do-air-pollutants-play-a-role-in-bowel-disease

New York Times:

http://well.blogs.nytimes.com/2013/07/11/air-pollution-may-raise-appendicitis-risk/

Reuters:

http://www.reuters.com/article/idUSTRE6685F920100709

ABC News:

http://abcnews.go.com/Health/PainNews/story?id=7726278&page=1

http://www.scientificamerican.com/article.cfm?id=do-air-pollutants-play-a-role-in-bowel-disease

http://well.blogs.nytimes.com/2013/07/11/air-pollution-may-raise-appendicitis-risk/

http://www.reuters.com/article/idUSTRE6685F920100709

http://abcnews.go.com/Health/PainNews/story?id=7726278&page=1

Gilaad G. Kaplan, MD, MPH

2

I Biographical Data

Gilaad G. Kaplan Bsc, MD, MPH, FRCPC

Teaching, Research and Wellness Building

University of Calgary

3280 Hospital Drive NW, 3E22

Calgary, Alberta

CANADA, T2N 4Z6

Telephone: 403 592 5015

Fax: 403 592 5090

Email: [email protected]

DOB: November 3, 1974

Citizenship: Canadian

Position: Associate Professor (Tenured)

Departments of Medicine and Community Health Sciences

Faculty of Medicine


II Academic Record

2007 Advanced Inflammatory Bowel Disease Fellow, Massachusetts General

Hospital, Harvard University, Boston, MA

2006 Masters of Public Health (Quantitative Methods), Harvard School of Public

Health, Harvard University, Boston, MA

2005 Certification (Gastroenterology), Royal College of Physicians and Surgeons

of Canada, Ottawa, ON

2004 Licensure (Internal Medicine), Royal College of Physicians and Surgeons

of Canada, Ottawa, ON

2000 Doctor of Medicine, University of Calgary, Calgary, AB

1997 Bachelor of Science, McMaster University, Hamilton, ON

III Awards and Distinctions

2015 Fostering Global Gastrointestinal Health, Highest Rated

Presentation, AGA Leadership Cabinet Meeting

2015 AGA Future Leaders Program, American

Gastroenterological Association

2015 Research Mentorship Excellence Award, Division of

Gastroenterology, University of Calgary

2014 American College of Gastroenterology Fellow Awards

(supervisor)

2014-2017 Eyes High Doctoral Recruitment Scholarship, University

of Calgary

$25,000/year

2013 Killam Laureate, Emerging Research Leader Award,

Killam Trusts

$5,000

mailto:[email protected]


3

2013 Young Investigator Award, Canadian Association of

Gastroenterology

2012 UEGW Travel Grant for Oral Presentation, United

European Gastroenterology Week Conference,

Amsterdam, The Netherlands.

$1,000

(Euro)

2012 Guest Speaker Award for highest rated talk in the 2011-

12 academic year, Department of Medicine Grand

Rounds, Dalhousie University, Halifax, NS

2012 Dean's Publication and Mentorship Prize, University of

Calgary

$10,000

2011 Avenue Magazine's “Calgary’s Top 40 Under 40”

2011 Internal Medicine Research Preceptor Award,

Department of Medicine, University of Calgary

2011 Research Mentorship Excellence Award, Division of


2011 Poster of Distinction. Digestive Disease Week. Chicago,

IL.

2010-2017 Alberta Heritage Foundation for Medical Research

(AHFMR) Population Health Investigator

$110,000/year

2010 Presidential Poster. American College of

Gastroenterology, San Antonio, Texas.

2009-2014 Canadian Institutes of Health Research (CIHR) New

Investigator Award

$60,000 /year

2009 Merit Award, Department of Medicine, University of

Calgary, Calgary, Alberta.

$5000

2009 2009 UEGW/WCOG Travel Award for “Air Pollution

and IBD: A Novel Association”, UEGW/WCOG

Conference, London, England.

$1,000

(Euro)

2009 Teaching Excellence Award, Division of


2008 2008 ACG Presidential Poster Award Recipient for

“Predicting postoperative mortality from comorbidity

indices in IBD patients.”

2006 ACG/Centocor IBD Abstract Award, American College

of Gastroenterology, Las Vegas, NV

$1,000

2006 Detweiler Traveling Fellowship, Royal College of

Physicians and Surgeons of Canada

$21,000

2005-2007 Canadian Institutes of Health Research, Clinical Research

Initiative Fellowship

$60,000 per

year

2005-2007 Alberta Heritage Foundation for Medical Research,

Clinical Fellowship

$10,000 per

year

2005 Gold Star Award for teaching, GI medical school course,


2004 Gold Star Award for clerkship teaching in internal

medicine, University of Calgary


4

2004 Poster of Distinction, Digestive Disease Week, New

Orleans

2003 Canadian Society for Clinical Investigation and Canadian

Institute of Health Research award for resident research

$1,000

IV Academic Appointments

2012- Associate Professor (Tenured), Departments of Medicine and Community

Health Sciences, University of Calgary

2007- Assistant Professor, Department of Community Health Sciences,


2007- Assistant Professor, Division of Gastroenterology, Department of

Medicine, University of Calgary

V Educational Activities

Undergraduate

Courses

Gastrointestinal Course (MDCN 408). 2007-

University of Calgary School of Medicine.

Responsible for providing lectures, small group precepting, and leading

GI clinical correlations.

MDSC 508, Primary Supervisor, Honours Thesis, Sam

Quan (2012-2013)

MDSC 528, Primary Supervisor of Sam Quan (2009-2010 and 2010-2012)

MDSC 528, Primary Supervisor of Chris Ma (2008-2009)

Med 440 Research Elective, Primary Supervisor of Chris Ma (2009-2012)

Med 440 Research Elective, Primary Supervisor of Michael Diamant

(2010-)

HSOC 408, Primary Supervisor of Debbie Boulton (2010-11)

Supervisor

Hashim Kareemi (Summer Studentship, 2010, 2011); Funded by a CAG

Summer Studentship Award (2011)

Samuel Quan (Summer Studentship, 2010, 2011, 2012, 2013, 2015).

Funded by a AHFMR/AI-HS Summer Studentship Awards (2010,

2011 & 2012)

Martin Prusinkiewicz (Summer Studentship, 2009), Funded by a AGA

Summer Studentship Award (2010)


5

Christopher Ma (Summer Studentship, 2008 & 2009). Funded by a

AHMFR Summer Studentship Award (2009)

Mollie Ferris, Medical Student Research Supervisor, 2008-2010.

Graduate

Courses MDCH 741 (Meta-Analysis Course), Instructor. 2011, 2012, 2014.

MDSC 755, Supervise Dean Yergens and Duyen Nguyen. 2011

Current Graduate Students (Primary or Co-Supervisor)

09/2012-

Primary

PhD (Epidemiology), Ellen Kuenzig, Department of

Community Health Sciences. Salary funded by an AIMS

Award.

09/2014 –

Primary

PhD (Epidemiology), Stephanie Coward, Department of Community

Health Sciences. Salary funded by Eyes High PhD Scholarship.

09/2015 - MSc (Epidemiology), Sangmin (Sarah) Lee, Department of Community

Health Sciences.

Graduate Students Defended Thesis (Primary or Co-Supervisor)

09/2010–14

Primary

PhD (Epidemiology), Alex Frolkis, Department of Community Health

Sciences. Thesis Defense May 16, 2014. Salary funded by AHFMR

Studentship Award.

09/2012-14

Primary

MSc (Epidemiology), Stephanie Coward, Department of Community

Health Sciences. Thesis Defense June 16, 2014.

05/2010–14

Co-

supervisor

PhD (Epidemiology), Maria Negron, Veterinary Medicine. Thesis Defense

June 27, 2014. Salary funded by an Eyes High International Doctoral

Scholarship.

01/2010-

12/12. Co-

supervisor

MSc, Fox Underwood, Department of Geography. Thesis Defense Dec 20,

2012. Salary funded by an Alberta IBD Consortium Trainee Award.

09/2009 – 12

Supervisor

MSc, Ing Soon, Department of Community Health Sciences. Thesis

Defense February 2012. Salary funded by Alberta Children's Hospital

Research Institute for Child and Maternal Health Clinical Research

Fellowship.

09/2009 –11

Supervisor

MSc, Natalie Molodecky, Department of Community Health Sciences.

Thesis Defense June 3, 2011. Salary funded by AHFMR Studentship.

Thesis Committee

2014- PhD Thesis Committee, Xiaoxiao Liu, Department of

Geography, Faculty of Social Sciences.


6

2014- PhD Thesis Committee, Michelle North, Department of

Ecosystem and Public Health, Faculty of Veterinary

Medicine

2012-2014 MSc Thesis Committee, Bushra Khokhar, Department of

Community Health Sciences.

2012-2014 MSc Thesis Committee, Bijoy Menon, Department of


2008-2010 MSc Thesis Committee, Jennifer deBruyn, Department of


Postgraduate

Supervisor Postdoctoral Fellow

Dr. Vineet Saini (2011-12), Co-Supervisor

Residents Supervised (Research):

Dr. Sunny Singh (2013-2015), Primary Supervisor

Dr. Ahmed Al-Darmaki (2013-2015), Primary Supervisor

Dr. Ali Rezaie (2010-2013), Primary Supervisor

Dr. Liisa Meddings (2007-2012), Primary Supervisor

Dr. Sonia Cerquozzi (2009-2011), Primary Supervisor

Dr. Mathew Sadler (2010-), Primary Supervisor

Dr. Rahim Kachra (2010-2013), Primary Supervisor

Inflammatory Bowel Disease Fellows Supervised:

Dr. Shani DeSilva (2008-2009), Co-Supervisor

Dr. Allen Lim (2009-2010), Co-Supervisor

Dr. Gordon Moran (2011-2012), Co-Supervisor

Dr. Ahmed Al-Darmaki (2015-), Primary Supervisor

VI Administrative Responsibilities

2015-2017 Member, Research Awards Panel, The American Gastroenterological

Association

2015- Member, Gairdner Lecture Planning Committee, Cumming School of

Medicine, University of Calgary

2015- Member, Secure Computing Program Steering Committee, Cumming

School of Medicine, University of Calgary

2014- Member, Executive Committee (Nominations and Awards Portfolio),

O’Brien Institute for Public Health, University of Calgary

2013- Member, Scientific and Medical Advisory Committee, Crohn’s and Colitis

Canada.

2013- Reviewer, Graduate Student Applications for Admissions, Department of

Community Health Sciences, University of Calgary.


7

2012-2013 Steering Committee Member (Canadian Association of Gastroenterology

Education Representative), IBD Connect Program

2011- Founder and Director, Environmental Health Research Group (EHRG),

O’Brien Institute for Public Health, University of Calgary

2011-2014 Member, Canadian Association of Gastroenterology Education Committee

2011 Search and Selection Committee for Head of the Division of


2011- Director of GI Resident Research, University of Calgary

2011- Executive Member, Graduate Education Committee, Division of


2011 Member, Advisory Board, Health Data Access Advisory Committee

(HDAAC), Alberta Health and Wellness.

2011- Steering Committee, National GEM Study, University of Toronto

2009 - Team Leader, Clinical and Population Health Studies, Alberta IBD

Consortium

Leading a team to study gene-environment-microbial interactions

in a population-based Alberta-wide cohort of IBD patients and

controls. Funded by a $5 million, 5 year AHFMR team grant.

2007 - Coordinator, GI Journal Club, University of Calgary

VII Professional Activities

Editorial Boards

2009- Section Editor, IBD Journal

Member, International Editorial Board, Alimentary Pharmacology &

Therapeutics 2016-

Grant Review Committees

2011 Faculty of Medicine Emerging Research Teams Grant Program (LOI

review committee), University of Calgary

2009 Canadian Institutes of Health Research

2009 Canadian Association of Gastroenterology

Grant Reviewer

2009- Broad Medical Research Program Grants

2009- Crohn’s and Colitis Foundation of Canada Grant Competition

Journal Reviewer

2012- Lancet

2009- American Journal of Gastroenterology

2009- Gastroenterology

2008 - IBD Journal

2007 - Liver International

2006 - Alimental Therapeutic Pharmacology

2009- Clinical Gastroenterology and Hepatology

Abstract Reviewer

2015- Abstract Poster Judge, Digestive Disease Week Conference, The

American Gastroenterological Association

2008 - AGA Abstract Reviewer for IBD: Epidemiology and Natural History


8

Membership

2010- O’Brien Institute for Public Health, University of Calgary

2008- BRIDGE, IBD Young Investigators Group

2007 - Inflammatory Bowel Disease Clinic, University of Calgary

2007 - Snyder Institute for Chronic Diseases, University of Calgary

2007 - Gastrointestinal Research Group, University of Calgary

2007 - Crohn’s and Colitis Foundation of Canada

2005 - Canadian Association of Gastroenterology

2005 - American Gastroenterological Association

2005 - Alberta Medical Association

2005 - Canadian Medical Association

Conference Chair

16/05/2015 Session Chair, IBD Epidemiology, Digestive Disease Week Conference,

Washington, DC.

02/2015 Session Chair, Optimization of Crohn's Therapy, Canadian Digestive

Disease Week Conference, Banff, Alberta

05/2014 Session Chair, IBD Epidemiology, Digestive Disease Week Conference,

Chicago, Illinois

02/2014 Session Chair, The Year in Review, Canadian Digestive Disease Week

Conference, Toronto, ON

03/2013 Session Chair, Breakfast with Experts, Difficult Cases in IBD, Canadian

Digestive Disease Week Conference, Victoria, BC

03/2013 Session Chair, Coming of Ages: Advances in IBD, Canadian Digestive

Disease Week Conference, Victoria, BC


Digestive Disease Week Conference, Montreal, Quebec

05/2011 Session Chair, IBD Surgery, Digestive Disease Week Conference,

Chicago, Illinois


Digestive Disease Week Conference, Vancouver, British Columbia

05/2010 Session Chair, Outcomes and Adverse Events Related to Treatment of

IBD, Digestive Disease Week Conference, New Orleans, Louisiana

02/2010 Breakfast with Experts, Difficult Cases in IBD, Canadian Digestive

Disease Week Conference, Toronto, Ontario

06/2009 Session Chair, Infections in IBD: Diagnosis, Consequences and

Management, Digestive Disease Week Conference, Chicago

02/2008 Small Group Chair, Environment and IBD Session, Canadian Digestive

Disease Week Conference, Montreal

Conference Organizer

2013- Co-Chair, Research Topics in GI Research, Canadian Association of

Gastroenterology

2009-2010 Gastrointestinal Research Group Annual Conference (2010)

Public Events & Community Engagement


9

10/06/2015 Webinar: “Tests, Tests, & More Tests”. Crohn’s and Colitis Canada.

10/02/2015 Presentation: “Your Poop” to Grade 2 classes of Westmount School.

06/26/2015 Launch of GoHere Program, Speaker, Crohn’s and Colitis Canada,

Calgary, Alberta

05/20/2015 Investigating the Causes of a Modern Disease of Modern Times, Speaker,

Dean’s Public Talk. University of Calgary, Calgary, AB.

05/11/2015 Our Cities, Our Health: How Urban Environments Impact Our Health.

Panel Member. CIHR Scientific Cafe. Calgary, Alberta.

05/04/2015 Dinner with the Dean. Speaker. University of Calgary, Calgary, AB.

05/2012 Environment, Genes and Gut Disease: Paradox of Prosperity, Organizer

and Panel Member. CIHR Scientific Cafe. Calgary, Alberta.

05/2011 Genetics, Environment, and Microbes. Panel Member. CIHR Scientific

Cafe. Toronto, ON.

05/2011 IBD and the Environment. CIHR Sponsored Journalist Workshop.

Toronto, ON.

02/2011 Genetics, Environment, and Microbes. Panel Member. CIHR Scientific

Cafe. Vancouver, BC.

VIII Research Support

Active Grants

2015-2016 Co-Principal Investigator. CIHR Catalyst Grant

(Methods in Post-Market Drug Safety and

Effectiveness Research) for “Bayesian models for

synthesizing random controlled trials and patients’

preferences for treatment options in early rheumatoid

arthritis and Crohn’s disease”.

$100,000

2014-2017 Principal Investigator. CIHR for “Preventing

Myocardial Infarctions with the Air Quality Health

Index”.

$74,138/year

2014-2017 Co-Principal Applicant. AI-HS PRIHS for

“Reassessment of Clinical Practices for Patient

Presenting to the Emergency Department with Upper

Gastrointestinal Bleeding”

$250,000/year

2014-2015 Principal Investigator. Health Canada for “Preventing

Strokes with the Air Quality Health Index”.

$30,000 (total)

2014-2019 Co-Investigator. CIHR Team Grant (Health

Challenges in Chronic Inflammation) for “Brain

Dysfunction in Chronic Inflammatory Disease:

Reciprocal Effects of CNS and Periphery Crosstalk”.

$500,000/year


Challenges in Chronic Inflammation) for “Nod-like

receptors: linking innate immunity and inflammation to

chronic disease”.

$500,000/year


Challenges in Chronic Inflammation) for “A

$500,000/year


10

Multidisciplinary Approach To Target Chronic

Inflammation Of The Gut, Liver And Joint”.


Challenges in Chronic Inflammation) for

“PRECISION: Preventing Complications from

Inflammatory Skin, Joint and Bowel Conditions”.

$500,000/year

2014-2016 Co-Investigator. CIHR for “The Effect of Air

Pollution in Developing Type 1 Diabetes Mellitus”

$59,125/year

2014-2017 Co-Investigator. CIHR for “Do altitude-related air

pressure differences influence susceptibility to

cardiovascular disease?”

$121,395/year

2013-2018 Co-Principal Applicant. CHILD-CIHR for “Canadian

Children Inflammatory Bowel Disease Network”.

$1,000,000/year

2013-2104 Co-Investigator. Clinical Research Award from the

American College of Gastroenterology for “Serological

technologies and profiles to deliver precision

diagnostics for inflammatory bowel disease patients.”

$35,000

2013-2016 Co-Investigator. CIHR for "An enhanced method to

measure chronic disease burdens using health

administrative data".

$60,681/year

Completed Grants

2013-15 Co-Investigator. Crohn's and Colitis Foundation of

Canada. Aberrant dendritic cell and T cell immune

function driven by IBD associated genetic mutations.

$100,000/year

2012-2015 Co-leader. The Faculty of Medicine's Emerging

Research Teams Grant Program for "A translational

approach to understanding and managing primary

sclerosing cholangitis."

$100,000/year

2011-2013 Principal Investigator. CIHR for “The effect of acute

air pollution exposure on the incidence of appendicitis:

a multi-city study.”

$89,567

/year

2011 Co-Principal Investigator. Canadian Foundation for

Innovation Leaders of Opportunity Funding for

“Translational Health Research Collaboratorium”.

$175,391(total)

2011 Co-Principal Investigator. Alberta Advanced

Education and Technology Small Equipment Grant

Program for “Translational Health Research

Collaboratorium”.

$175,391(total)

2011-2013 Principal Investigator. Shire Pharmaceutical contract

for " The Incidence, Morbidity and Mortality of

Diverticulitis"

$179,180 (total,

includes

overhead)

2011-2012 Principal Investigator. Abbott Pharmaceutical contract

for "Long-Term Outcomes Following Colectomy for

Ulcerative Colitis"

$76,232 (total,

includes

overhead)


11

2010 Co-Investigator. Department of Medicine Research

Fund for "Pregnancy Outcomes in IBD"

$10,000

2010-2013 Co-Investigator. Crohn’s and Colitis Foundation of

Canada Grant in Aid for “Genetic Markers of

Outcomes in Crohn’s Disease.”

$125,000/year

2010-2013 Alberta Heritage Foundation for Medical Research Population Health Investigator, Establishment Grant

$100,000/year

2009-2010 Principal Investigator, Health Canada contract for “Air

Pollution and Appendicitis”.

$100,000

2009-2014 Co-investigator. AHFMR Team Grant for “Etiology of

Inflammatory Bowel Disease: Gene, Microbe, &

Environment Interactions.”

$1,000,000

/year

2008-2010 Principal Investigator. MSI Foundation for

“Postoperative outcomes in elderly ulcerative colitis

patients following colectomy.”

$23,400

/year

2008-2010 Co-Principal Investigator. CIHR for “The effect of

outdoor air pollution on the development and the

prognosis of the inflammatory bowel diseases in

Canada.”

$96,696

/year

2008-2010 Principal Investigator. Canadian Association of

Gastroenterology for “The effect of outdoor air

pollution on the inflammatory bowel diseases.”

$42,300 /year

2009-2010 Principal Investigator. Health Canada contract for

“The effect of outdoor air pollution on the development

and prognosis of the inflammatory bowel diseases in

Canada.”

$49,400 (total,

includes

overhead)

2007-2008 Principal Investigator. Broad Medical Research

Program for “The effect of air pollution on the

development of the inflammatory bowel disease in

England and Wales.”

$90,200

IX Invited Addresses

1. 09/01/2016 Investigating the Cause of a Modern Disease of Modern Times.

Conquering Crohn’s and Colitis, Patient Education Day. University of

Calgary, Calgary, AB.

2. 07/11/2015 Dietary & Environmental Questions in IBD. Canada Future Directions in

IBD. Crohn’s and Colitis Canada. Toronto, ON.

3. 05/26/2015 Collaborative Research in Gastroenterology and Rheumatology. Immune

Mediated Inflammatory Disease Working Group Seminar. Calgary, AB.

4. 04/30/2015 IBD in the Next Decade: Preparing for the Challenges Ahead.

Gastroenterology Rounds, Northwestern University, Chicago, IL.

5. 04/24/2015 Globalization of IBD: Meeting the Challenges of the Next Decade.

International Organization of IBD, Montreal, Canada.


12

6. 04/18/2015 The Global Rise of IBD: Comparing the Western World to Asia. Digestive

Endoscopy & Gastrointestinal Disease Conference, Beijing, China.

7. 04/16/2015 Development of a Surveillance Cohort: The Alberta Experience. Peking

Union College Medical Hospital Gastroenterology Rounds, Beijing,

China.

8. 04/16/2015 Use of Secondary Data in Gastrointestinal Research. Peking Union

College Medical Hospital Epidemiology Rounds, Beijing, China.

9. 02/25/2015 Genes, Environment, and Microbes: Lessons from Inflammatory Bowel

Disease. Alberta Children’s Hospital Research Institute Healthy Outcomes

Theme Rounds, University of Calgary.

10. 30/01/2015 Genes, Environment, and Microbes: Lessons from the Inflammatory

Bowel Diseases and its Overlap with Asthma. Respiratory Clinical

Academic Rounds, University of Calgary.

11. 05/11/2014 IBD and the Environment: Past, Present, and Future. Fancombe Rounds,

McMaster University, Hamilton, ON.

12. 30/09/2014 Panelist, Thought Leader Forum on Coal and Health, University of

Calgary.

13. 19/09/2014 The Clinician Scientists: An Unexpected Journey. Leaders in Medicine,

University of Calgary, Calgary, Alberta.

14. 16/05/2014 Colectomy for Ulcerative Colitis: The dodo bird of UC management?

Gastroenterology Rounds, University of Calgary.

15. 05/05/2014 Minimizing risk in the pre- and post-operative period. Symposium: Severe

Colitis: more medicines or time for surgery? Digestive Disease Week,

Chicago, IL.

16. 21/03/2014 The Health Improvement Network (THIN) Database, The Department of

Community Health Sciences and the Institute for Public Health Seminar,

University of Calgary.

17. 27/02/2014 The Global Rise of IBD. Gastroenterology Rounds. University of Texas

Southwestern (UTSW). Dallas, TX.

18. 10/02/2014 Non-response to anti-TNF therapy. Canadian Digestive Disease Week.

Toronto, ON.

19. 31/01/2014 Environmental Health Research in the 21st Century: IBD as a Model.

Autoimmune Disease Network. University of Calgary, Calgary, AB.

20. 20/01/2014 The Global Burden of IBD, Working Together for Better Health

Symposium, University of Calgary.

21. 26/06/2013 Opportunities and Challenges to Advance Environmental Health Research.

Plenary Symposium. Canadian Society for Epidemiology and Biostatistics

Biennial Conference, St. John’s, NL.

22. 31/05/2013 Preventing Colectomies in Ulcerative Colitis. Hot Topics in

Gastroenterology, Annual GI Forum. University of Manitoba. Winnipeg,

MB.

23. 08/05/2013 The Global Rise of IBD. Rotary Club. Calgary, AB.

24. 11/04/2013 Advisory Board Presentation, CIHR’s Institute of Health Services and

Policy Research, Calgary, Alberta


13

25. 03/03/2013 IBD in the Year 2023: Challenges and Opportunities. 2013 Canadian

Association of Gastroenterology Young Investigator Award Lecture.

Canadian Digestive Disease Week Conference. Victoria, BC.

26. 01/03/2013 The Global Rise of IBD. Canadian Digestive Disease Week Conference.

Victoria, BC.

27. 26/02/2013 Lessons from a Regional IBD Cohort in Calgary, Canada. CCFA-CDC

Epidemiologic Research in IBD Meeting. Philadelphia, Pennsylvania.

28. 11/2012 IBD and the Elderly. Western Canadian IBD Symposium. Banff, AB.

29. 11/2012 IBD and EIM: What is the right treatment? Immune Mediated

Inflammatory Disease Working Group Seminar. Calgary, AB.

30. 06/2012 IBD: The New Epidemiology of a Global Disease. Department of

Medicine Grand Rounds, Dalhousie University, Halifax, NS.

31. 06/2012 The Sick Ulcerative Colitis Patient: 21st Century Approach to

Management. St. Joseph Hospital, Hamilton, ON


Management. Sunnybrook Hospital, Toronto, ON


Management. South Western Ontario Gastroenterology Association

Annual Conference, ON

34. 04/2012 IBD: The New Epidemiology of a Global Disease. Crohn's and Colitis

Foundation of America (CCFA) Education Symposium, Chicago, Illinois.


Management. Gut Journal Club. Edmonton, Alberta.

36. 03/2012 Genetics, Environment and the Inflammatory Bowel Diseases. CCFC

Chapter Symposium. Lethbridge, Alberta.

37. 03/2012 Air Pollution and IBD: Blowing Smoking?, Alberta Occupational and

Environmental Health Symposium, Calgary, Alberta.

38. 02/2012 The Environment and IBD: Challenges and Future Directions, CIHR

Workshop 'Environment, Genes, and Chronic Diseases', Ottawa, Ontario.

39. 11/2011 IBD and the Environment, Canada Future Directions in IBD, Toronto,

Ontario.

40. 11/2011 Rising Star Seminar: How do I succeed in IBD, Canada Future Directions

in IBD, Toronto, Ontario.

41. 06/2011 Environment and IBD, Memorial University, Department of Medicine

Grand Rounds, St. Johns, NFLD

42. 06/2011 Ulcerative Colitis Management in the 21st Century, Dalhousie University

GI Rounds, Halifax, NB

43. 06/2011 Environment and IBD, McGill University, Royal Victoria Hospital, GI

Rounds, Montreal, QB

44. 06/2011 Environment and IBD, University of Ottawa, GI Rounds, Ottawa, ON

45. 06/2011 Ulcerative Colitis Management in the 21st Century, St. Mikes Hospital, GI

Rounds, Toronto, ON

46. 06/2011 The Top Clinical Studies from Administrative Databases, Post DDW

Review Course, Lake Louise, Alberta

47. 03/2011 Air pollution as a trigger for the inflammatory bowel disease.

Gastrointestinal Research Group Conference, Banff, AB


14

48. 03/2011 Perianal Crohn’s disease and refractory ulcerative proctitis, Small Group

Session, Canadian Digestive Disease Week, Vancouver, BC

49. 02/2011 Biostats primer for researchers. Research Topics Meetings. Vancouver,

BC

50. 12/2010 Ulcerative colitis management in the 21st century. GI Seminars. Regina,

SK.

51. 11/2010 Ulcerative colitis management in the 21st century. GI Seminars. Saskatoon,

SK.

52. 09/2010 Optimizing outcomes in ulcerative colitis. Grand Rounds. Hospital for

Sick Children. Toronto, ON

53. 09/2010 Air Pollution: A Gastroenterologist’s Perspective. Research Seminar.

Mount Sinai Hospital, Toronto, ON

54. 08/2010 Air Pollution: A Gastroenterologist’s Perspective. Medical School

Reunion. CME Talk. Kananaskis, Alberta

55. 06/2010 The Presidential Posters, Post DDW Review Course, Lake Louise, Alberta

56. 05/2010 Biologics in Ulcerative Colitis and Crohn’s Disease, B.C. Digestive

Disease Weekend, Victoria, BC.

57. 05/2010 Epidemiology of IBD: Clues to Pathogenesis, CME Talk, Division of


58. 02/2010 The Environment and IBD: Challenge and Progress, Department of

Community Health Sciences Seminar Rounds, University of Calgary

59. 01/2010 Appendicitis and Air Pollution: Clues to Pathogenesis, Internal Medicine

Grand Rounds, University of Calgary

60. 11/2009 IBD: Molecules to Medicines, Research Rounds, Tel Aviv University, Tel

Aviv, Israel

61. 11/2009 Population-based Alberta IBD Study. CCFC and You Symposium,

Calgary, Alberta.

62. 11/2009 Appendicitis and Air Pollution – A Novel Association, Gastroenterology

Grand Rounds, University of Manitoba, Winnipeg, Manitoba

63. 09/2009 Combination Therapy in IBD – The Final Word, Alberta Society of

Gastroenterology Annual Meeting, Kananaskis, Alberta

64. 04/2009 Progress and challenges measuring the impact of the environment on IBD,

IBD 2009, Toronto, Ontario

65. 04/2009 Predicting outcomes and changing natural history in Crohn’s disease,

CME GI Grand Rounds, New York University School of Medicine, New

York, New York

66. 04/2009 Predicting outcomes and changing natural history in Crohn’s disease,

CME Grand Rounds, Cleveland Clinic, Florida

67. 03/2009 Tools to predict outcomes in Crohn’s disease, CME Grand Rounds,

Wright State University, Dayton, Ohio

68. 02/2009 IBD: Past, Present, and Future, CAG Symposium, CDDW, Banff, Alberta

69. 02/2009 Air Pollution and IBD: A Novel Association, Broad Medical Research

Program Investigator Meeting, Los Angeles, California.

70. 01/2009 Environmental Perspectives in IBD, Epidemiology Seminar Rounds,

Karolinski Institute, Stockholm, Sweden


15

71. 11/2008 Optimizing Postoperative Outcomes in IBD, Western Canada IBD

Symposium, Lake Louise, Alberta.

72. 11/2008 Epidemiology of IBD: Clues for future research, Canadian GI Resident

Program in IBD, Calgary, Alberta

73. 10/2008 Gene-environment interactions in IBD: Clues to Pathogenesis, Canadian

MAP Researchers Meeting, Banff, Alberta

74. 09/2008 Environment and IBD: A Translational Approach, Alberta Society for

Gastroenterology, Banff, Alberta

75. 09/2008 Translational Research in IBD, Snyder III Research Day, University of

Calgary, Calgary

76. 01/2008 Air Pollution and IBD, Health Canada, Ottawa, Ontario

77. 01/2008 Administrative databases for IBD Research, Gastrointestinal Research

Group Conference, Banff, Alberta

78. 11/2007 Environmental Risk Factors of IBD. Gastrointestinal Research Group

Seminars, Calgary, Alberta

79. 11/2007 IBD and the Environment. Western Canada IBD Retreat, Banff, Alberta

80. 09/2007 Historical Perspective on Ulcerative Colitis, Department of Medicine

Grand Rounds, University of Calgary

81. 11/2004 Probiotics and IBD. Western Canada IBD Retreat, Banff, Alberta

X Publications

Peer Reviewed Manuscripts (Trainees underlined, *Corresponding Author)

1. ME Negrón, A Rezaie, HW Barkema, K Rioux, J De Buck, S Checkley, PL Beck, M Carroll,

RN Fedorak, L Dieleman, R Panaccione, S Ghosh, and GG Kaplan*. Ulcerative colitis

patients with Clostridium difficile are at increased risk of death, colectomy, and post-

operative complications: A population-based inception cohort study. American Journal of

Gastroenterology. 2016 In press.

2. MJ Diamant, S Schaffer, S Coward, ME Kuenzig, J Hubbard, B Eksteen, S Heitman, R

Panaccione, S Ghosh, GG Kaplan*. Smoking is Associated with an Increased Risk for

Surgery in Diverticulitis: A Case Control Study. PLoS One. 2016 In press.

3. CA Atta, KM Fiest, AD Frolkis, N Jette, T Pringsheim, C Germaine-Smith, T Rajapakse, JI

Roberts, Jonathan Dykeman, GG Kaplan, & A Metcalfe. Global birth prevalence of spina

bifida: A systematic review and meta-analysis of regional differences by folic acid

fortification status. American Journal of Public Health. 2016 Jan;106(1):159.

4. Fort Gasia M, Ghosh S, Panaccione R, Ferraz JG, Kaplan GG, Leung Y, Novak KL, Seow

CH, Iacucci M. An Audit of Surveillance Colonoscopy Practice in Inflammatory Bowel

Disease using Dye Chromoendoscopy, Electronic Virtual Chromoendoscopy or White light

High Definition Colonoscopy with Either Targeted or Random Biopsies. Clinical

Gastroenterol. and Hepatology. 2016 Jan 21 [Epub ahead of print].

5. Kaplan GG*. The Global Burden of Inflammatory Bowel Disease: From 2015 to 2025.

Nature Reviews: Gastroenterology and Hepatology. 2015 Dec;12(12):720-7.


16

6. SM Devlin, GY Melmed, PM Irving, DT Rubin, A Kornbluth, PL Kozuch, LE Raffals, FS

Velayos, MP Sparrow, L Baidoo, B Bressler, AS Cheifetz, J Jones, GG Kaplan, CA Siegel.

Recommendations for Quality Colonoscopy Reporting for Inflammatory Bowel Disease

Patients: Results from a RAND-Appropriateness Panel. Inflamm Bowel Dis. 2015 In press.

7. KL Novak, D Jacob, GG Kaplan, E Boyce, S Ghosh, I Ma, C Lu, S Wilson, R Panaccione.

Point of Care Ultrasound Accurately Distinguishes Inflammatory from Non-Inflammatory

Disease in Patients Presenting with Abdominal Pain and Diarrhea. Canadian Journal of

Gastroenterology & Hepatology. 2015 In press.

8. Kevans D, Tyler AD, Holm K, Jørgensen KK, Vatn MH, Karlsen TH, Kaplan GG, Eksteen

B, Gevers D, Hov JR, Silverberg MS. Characterization of Intestinal Microbiota in Ulcerative

Colitis Patients with and without Primary Sclerosing Cholangitis. J Crohns Colitis. 2015 Nov

2. [Epub ahead of print]

9. C Blackmore, D Tanyingo, GG Kaplan, E Dixon, AR MacLean, CG Ball. A Comparison of

Outcomes between Laparoscopic and Open Appendectomy in Canada. Canadian Journal of

Surgery. 2015 Dec;58(6):431-2.

10. J deBruyn, K Fonseca, S Ghosh, R Panaccione, MF Gasia, A Ueno, GG Kaplan, CH Seow, I

Wrobel. Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel

Disease on Maintenance Infliximab Therapy: A Randomized Trial. Inflamm Bowel Dis. 2015

Nov 20 [Epub ahead of print].

11. M Peng, G Chen, GG Kaplan, LM Lix, N Drummond, K Lucyk, S Garies, M Lowerison, S

Wiebe, H Quan. Methods of defining hypertension in electronic medical records-validation

again national survey data. Journal of Public Health. 2015 Nov 6 [Epub ahead of print].

12. C Brown, PR Gibson, A Hart, GG Kaplan, S Kachroo, Q Ding, E Hautamaki, T Fan, CM

Black, X Hu, K Beusterien. Long-term outcomes of colectomy surgery among patients

with ulcerative colitis. Springer Plus; 2015 Oct 5; 4:573.

13. S Quan, H Yang, D Tanyingoh, PJ Villeneuve, DM Stieb, M Johnson, R Hilsden, K Madsen,

SV van Zanten, K Novak, E Lang, S Ghosh, and GG Kaplan*. Upper Gastrointestinal

Bleeding due to Peptic Ulcer Disease is Not Associated with Air Pollution: A Case-

Crossover Study. BMC Gastroenterol. 2015 Oct 14; 15(1):131.

14. JXQ. Pang, E Ross, MA Borman, S Zimmer, GG Kaplan, SJ Heitman, MG Swain, KW

Burak, H Quan, RP Myers. Validation of coding algorithms for the identification of patients

hospitalized for alcoholic hepatitis using administrative data. BMC Gastroenterol. 2015 Sept

11; 15(1): 116.

http://www.ncbi.nlm.nih.gov/pubmed/26526357



17

15. S Bertazzon, M Johnson, K Eccles, GG Kaplan. Accounting for spatial effects in land use

regression for air pollution modelling. Spatial and Spatio-temporal Epidemiology. 2015 Oct;

14-15: 9-21.

16. Jones JL, Kaplan GG, Peyrin-Biroulet L, Baidoo L, Devlin S, Melmed GY, Tanyingoh D,

Raffals L, Irving P, Kozuch P, Sparrow M, Velayos F, Bressler B, Cheifetz A, Colombel J-F,

Siegel CA. Impact of concomitant immunomodulator treatment on efficacy and safety of

anti-TNF therapy in Crohn’s disease: a meta-analysis of subgroups using patient level data

from placebo controlled trials. Clinical Gastroenterol. and Hepatology. 2015

Dec;13(13):2233-2240.

17. K Novak, D Tanyingoh, F Petersen, T Kucharzik, R Panaccione, S Ghosh, GG Kaplan, A

Wilson, K Klaus and C Maaser. Clinic-based point of care transabdominal ultrasound for

monitoring crohn’s disease: impact on clinical decision making. Journal of Crohn's and

Colitis. 2015 Sep; 9(9):795-801.

18. S Singh, A Al-Darmaki, AD Frolkis, CH Seow, Y Leung, KL Novak, S Ghosh, B Eksteen, R

Panaccione and GG Kaplan*. Post-operative Mortality Among Patients With Inflammatory

Bowel Diseases: A Systematic Review and Meta-Analysis of Population-based Studies

Gastroenterology. 2015 Oct; 149(4):928-37.

19. A Rezaie, ME Kuenzig, EI Benchimol, AM Griffiths, AR Otley, AH Steinhart, GG Kaplan,

CH Seow. Budesonide for induction of remission in Crohn's disease. Cochrane Database Syst

Rev. 2015 Jun 3; 6:CD000296.

20. S Coward, SJ Heitman, F Clement, J Hubbard, M Proulx, S Zimmer, R Panaccione, C Seow,

Y Leung, N Datta, S Ghosh, R Myers, M Swain, and GG Kaplan*. Ulcerative Colitis

Associated Hospitalization Costs: A Population-Based Study. Can J Gastroenterol Hepatol.

2015 Oct; 29(7): 357-62.

21. GW Moran, M Dubeau, GG Kaplan, H Yang, B Eksteen, S Ghosh and R Panaccione.

Clinical predictors of thiopurine-related adverse events in Crohn's disease. World J

Gastroenterol. 2015 Jul 7; 21(25): 7795-804.

22. S Bernatsky, A Smargiassi, M Johnson, GG Kaplan, C Barnabe, L Svenson, A Brand, S

Bertazzon, M Hudson, AE Clarke, P Fortin, S Edworthy, P Bélisle, L Joseph. Fine particulate

air pollution, nitrogen dioxide, and systemic autoimmune rheumatic disease in Calgary,

Alberta. Environmental Research. 2015 May 15;140:474-478.

23. MJ. Diamant, Coward S, WD. Buie, AR. MacLean, E Dixon, CG. Ball, S Schaffer, GG.

Kaplan*. The Effect of Hospital Volume on in-Hospital Mortality Among Diverticulitis

Patients - a Nationwide Analysis. Can J Gastroenterol Hepatol. 2015 May;29(4):193-7.


18

24. M Iacucci, MF Gasia, R Panaccione, GG Kaplan, S Ghosh, X Gui. Complete mucosal healing

defined by endoscopy Mayo subscore still demonstrates abnormalities by novel iSCAN

endoscopic and refined histological gradings. Endoscopy. 2015 Aug; 47(8):726-34.

25. GS Hazlewood, A Rezaie, M Borman, R Panaccione, S Ghosh, CH Seow, E Kuenzig, G

Tomlinson, CA Siegel, GY Melmed, GG Kaplan*. Comparative Effectiveness of

Immunosuppressant and Biologics for Inducing and Maintaining Remission in Crohn's

Disease: A Network Meta-Analysis. Gastroenterology. 2015 Feb; 148(2): 344-354.

26. J Pang, E Ross, M Borman, S Zimmer, GG Kaplan, S Heitman, M Swain, K Burak, H Quan,

R Myers. Risk factors for mortality in patients with alcoholic hepatitis and assessment of

prognostic models: a population-based study. Can J Gastroenterol Hepatology. 2015 Apr;

29(3): 131-138.

27. YPY Leung, GG Kaplan, S Coward, D Tanyingoh, BJ Kaplan, DW Johnston, HW Barkema,

S Ghosh, R Panaccione, and CH Seow. Intrapartum corticosteroid use significantly increases

the risk of gestational diabetes in women with inflammatory bowel disease. Journal of

Crohn's and Colitis. 2015 Mar; 9(3): 223-30.

28. Helen Becker, Daniel Grigat, Subrata Ghosh, GG. Kaplan, Levinus Dieleman, Richard

Fedorak, Remo Panaccione, and HW. Barkema. Living with Inflammatory Bowel Disease –

a Crohn’s and Colitis Canada survey. Can J Gastroenterol Hepatol. 2015 Mar; 29(2): 77-84.

29. GG Kaplan*, A Lim, CH Seow, GW Moran, S Ghosh, Y Leung, J Debruyn, GC Nguyen, J

Hubbard, and R Panaccione. Colectomy is a risk factor for venous thromboembolism in

ulcerative colitis. World J Gastroenterol. 2015 January; 21(4) 1251-1260.

30. S Coward, SJ Heitman, F Clement, M Negron, R Panaccione, S Ghosh, HW Barkema, C

Seow, YPY Leung, and GG Kaplan*. Funding a Smoking Cessation Program for Crohn’s

Disease: An Economic Evaluation. Am J Gastroenterol. 2015 Mar; 110(3): 368-77.

31. M Iacucci, C Hassan, M Fort Gasia, S Urbanski, X Gui, G Eustace, G Kaplan, B Eksteen, R

Panaccione. Serrated adenoma prevalence in inflammatory bowel disease surveillance

colonoscopy, and characteristics revealed by chromoendoscopy and virtual

chromoendoscopy. Can J Gastroenterol Hepatol. 2014 Dec; 28 (11): 589-594.

32. MD Sadler, NC Ravindran, J Hubbard, RP Myers, S Ghosh, PL Beck, E Dixon, Chad Ball, C

Prusinkiewicz, SJ Heitman, and GG Kaplan*. Predictors of Mortality Among Patients

Undergoing Colectomy for Ischemic Colitis: A Population-Based U.S. Study. Can J

Gastroenterol Hepatol. 2014 Dec; 28 (11): 600-4.

33. LM Stinton, C Bentow, M Mahler, GL Norman, B Eksteen, AL Mason, GG Kaplan, B

Lindkvist, GM Hirschfield, P Milkiewicz, A Cheung, HL Janssen, MJ Fritzler. PR3-ANCA:


19

a promising biomarker in primary sclerosing cholangitis (PSC). PLoS One. 2014 Nov

14;9(11):e112877.

34. GG Kaplan*. Global variations in environmental risk factors for the inflammatory bowel

diseases. Nature Reviews Gastroenterology and Hepatology. 2014 Dec;11(12):708-9.

35. Negrón ME, Kaplan GG, Barkema HW, Eksteen B, Clement F, Manns BJ, Coward S,

Panaccione R, Ghosh S, Heitman SJ. Colorectal Cancer Surveillance in Patients with

Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: An Economic Evaluation.

Inflamm Bowel Dis. 2014 Nov; 20(11):2046-55.

36. Kuenzig ME, Rezaie A, Seow CH, Otley AR, Steinhart AH, Griffiths AM, Kaplan GG,

Benchimol EI. Budesonide for maintenance of remission in Crohn's disease. Cochrane

Database Syst Rev. 2014 Aug 21;8:CD002913. [Epub ahead of print]

37. AD Frolkis, DS Lipton, KM Fiest, ME Negrón, J Dykeman, J deBruyn, N Jette, T Frolkis, A

Rezaie, CH Seow, R Panaccione, S Ghosh, GG Kaplan*. Cumulative incidence of second

intestinal resection in Crohn’s disease: a systematic review and meta-analysis of population-

based studies. Am J Gastroenterol. 2014 Nov; 109(11):1739-1748.

38. S Quan, A Frolkis, K Milne, N Molodecky, H Yang, E Dixon, CG. Ball, RP Myers, S Ghosh,

R Hilsden, S Veldhuyzen van Zanten, and GG. Kaplan*. Upper-Gastrointestinal Bleeding

Secondary to Peptic Ulcer Disease: Incidence and Outcomes. World Journal of

Gastroenterology. 2014 Dec 14; 20(46): 17568-17577.

39. ME Negrón, HW Barkema, K Rioux, J De Buck, S Checkley, M Proulx, A Frolkis, PL

Beck, LA Dieleman, R Panaccione, S Ghosh, GG Kaplan*. Clostridium Difficile Infection

Worsens the Prognosis of Ulcerative Colitis. Can J Gastroenterol Hepatol. 2014

July/August; 28(7):373-380.

40. Z Kassam, S Belga, I Roifman, S Hirota, H Jijon, GG Kaplan, S Ghosh, PL Beck.

Inflammatory Bowel Disease Cause-Specific Mortality: A Primer for Clinicians. Inflamm

Bowel Dis. 2014 Dec; 20(12):2483-92. 2014 Sept 2 [Epub ahead of print].

41. KM Reich, HJ Chang, A Rezaie, H Wang, KJ Goodman, GG Kaplan, LW Svenson, G Lees,

RN Fedorak, KI Kroeker. The Incidence Rate of Colectomy for Medically-Refractory

Ulcerative Colitis has Declined in Parallel with Increasing Anti-TNF Use: A Time-Trend

Study. Alimentary Pharmacology & Therapeutics. 2014 Sept; 40(6): 629-38.

42. A Frolkis, GG Kaplan, A Patel, P Faris, H Quan, N Jette, J deBruyn. Short-term emergent

readmission and postoperative complications in children and adults with inflammatory bowel



http://www.ncbi.nlm.nih.gov/pubmed?term=Kuenzig%20ME%5BAuthor%5D&cauthor=true&cauthor_uid=25141071

http://www.ncbi.nlm.nih.gov/pubmed?term=Rezaie%20A%5BAuthor%5D&cauthor=true&cauthor_uid=25141071

http://www.ncbi.nlm.nih.gov/pubmed?term=Seow%20CH%5BAuthor%5D&cauthor=true&cauthor_uid=25141071

http://www.ncbi.nlm.nih.gov/pubmed?term=Otley%20AR%5BAuthor%5D&cauthor=true&cauthor_uid=25141071

http://www.ncbi.nlm.nih.gov/pubmed?term=Steinhart%20AH%5BAuthor%5D&cauthor=true&cauthor_uid=25141071

http://www.ncbi.nlm.nih.gov/pubmed?term=Griffiths%20AM%5BAuthor%5D&cauthor=true&cauthor_uid=25141071

http://www.ncbi.nlm.nih.gov/pubmed?term=Kaplan%20GG%5BAuthor%5D&cauthor=true&cauthor_uid=25141071

http://www.ncbi.nlm.nih.gov/pubmed?term=Benchimol%20EI%5BAuthor%5D&cauthor=true&cauthor_uid=25141071




20

disease who undergo intestinal resection – A population-based study. Inflamm Bowel Dis.

2014 Aug 20(8): 1316-23.

43. IS Soon, JCC deBruyn, J Hubbard, I Wrobel, R Sauve, DL Sigalet, GG Kaplan*. Rising

post-colectomy complications in children with ulcerative colitis despite stable colectomy

rates in United States. Journal of Crohn's and Colitis. 2014 Nov 1; 8(11):1417-26.

44. SY Salim, J Jovel, E Wine, GG Kaplan, R Vincent, A Thiesen, HW Barkema, KL Madsen.

Exposure to Ingested Airborne Pollutant Particulate Matter Increases Mucosal Exposure to

Bacteria and Induces Early Onset of Inflammation in Neonatal IL-10 Deficient Mice.

Inflamm Bowel Dis. 2014 Jul; 20(7): 1129-38.

45. Ball CG, Dixon E, MacLean AR, Kaplan GG, Nicholson L, Sutherland FR. The impact of

an acute care surgery clinical care pathway for suspected appendicitis on the use of CT in the

emergency department. Can J Surg. 2014 Jun; 57(3):194-8.

46. GC. Nguyen, SM. Devlin, W Afif, B Bressler, SE. Gruchy, GG. Kaplan, L Oliveira, S

Plamondon, CH. Seow, C Williams, K Wong, BM. Yan, J Jones. Defining quality indicators

for best-practice management of inflammatory bowel disease in Canada. Can J

Gastroenterol. 2014; 28(5): 275-285.

47. JXQ Pang, S Zimmer, S Niu, P Crotty, J Tracey, F Pradhan, AM Shaheen, CS Coffin, S

Heitman, GG Kaplan, MG Swain, RP Myers. Liver stiffness by transient elastography

predicts liver-related complications and mortality in patients with chronic liver disease.

PLOS One. 2014 Apr 22; 9(4):e95776.

48. Pang JX, Pradhan F, Zimmer S, Niu S, Crotty P, Tracey J, Schneider C, Heitman SJ, Kaplan

GG, Swain MG, Myers RP. The feasibility and reliability of transient elastography using

Fibroscan: A practice audit of 2335 examinations. Can J Gastroenterol. 2014 Mar;

28(3):143-9.

49. Moran GW, Dubeau MF, Kaplan GG, Panaccione R, Ghosh S. Novel concepts in

inflammatory bowel disease. Br Med Bull. 2014; 109:55-72. Epub 2014 Feb 5.

50. A Ueno, H Jijon, S Traves, R Chan, K Ford, PL Beck, M Iacucci, MF Gasia, HW Barkema,

R Panaccione, GG Kaplan, D Proud, S Ghosh. Opposing effects of smoking in ulcerative

colitis and Crohn’s disease may be explained by differential effects on dendritic cells.

Inflamm Bowel Dis. 2014 May; 20(5): 800-810.

51. Long MD, Hutfless S, Kappelman MD, Khalili H, Kaplan GG, Bernstein CN, Colombel JF,

Gower-Rousseau C, Herrinton L, Velayos F, Loftus EV Jr, Nguyen GC, Ananthakrishnan

AN, Sonnenberg A, Chan A, Sandler RS, Atreja A, Shah SA, Rothman K, Leleiko NS,

Bright R, Boffetta P, Myers KD, Sands BE. Challenges in Designing a National Surveillance










21

Program for Inflammatory Bowel Disease in the United States. Infamm Bowel Dis. 2014 Feb;

20(2): 398-415.

52. Storr M, Devlin S, Kaplan GG, Panaccione R, Andrews CN. Cannabis use provides

symptom relief in patients with inflammatory bowel disease but is associated with worse

disease prognosis in patients with Crohn’s disease. Inflamm Bowel Dis. 2014 Mar; 20(3):

472-80.

53. KA. Johannson, E Vittinghoff, K Lee, JR. Balmes, GG. Kaplan, DS Kim, and HR. Collard.

Acute Exacerbation of Idiopathic Pulmonary Fibrosis Associated with Air Pollution

Exposure. Eur Respir J. 2014 Apr; 43(4): 1124-21.

54. Paul D. James, GG Kaplan, Robert P. Myers, James Hubbard , Abdel Aziz M Shaheen, Jill

Tinmouth, Elaine Yong, Jonathan Love, and Steven J. Heitman. Decreasing mortality from

acute biliary diseases requiring endoscopic retrograde cholangiopancreatography: A

nationwide cohort study. Clinical Gastroenterol. and Hepatology. 2014 July; 12(7): 1151-59.

55. Saad Y Salim, Gilaad G. Kaplan, Karen L Madsen. Air pollution effects on the gut

microbiota: A link between exposure and inflammatory disease. Gut Microbes. 2014; Mar-

Apr; 5(2): 215-219.

56. GW Moran, M Dubeau, GG Kaplan, H Yang, CH Seow, RN Fedorak, LA Dieleman, HW

Barkema, S Ghosh, R Panaccione. Phenotypic features of Crohn's disease associated with

failure of medical treatment. Clin Gastroenterol Hepatol. 2014 Mar; 12(3):434-42.

57. GW Moran, AW Lim, JL Bailey, M Dubeau, Y Leung, SM Devlin, K Novak, GG Kaplan,

M Iacucci, C Seow, L Martin, R Panaccione, and S Ghosh. Review Article: Dermatological

complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease.

Aliment Pharmacol Ther 2013 November; 38(9): 1002-1024.

58. AD Frolkis, J Dykeman, ME Negron, J deBruyn, N Jette, KM Fiest, T Frolkis, H Barkema,

KP Rioux, R Panaccione, S Ghosh, S Wiebe, GG Kaplan*. Risk of Surgery for the

Inflammatory Bowel Diseases has Decreased Over Time: A Systematic Review and Meta-

Analysis of Population-Based Studies. Gastroenterol. Nov 2013;145(5):996-1006.

59. A Ueno, H Jijon, R Chan, K Ford, C Hirota, GG Kaplan, PL Beck, M Iacucci, MF Gasia,

HW Barkema, R Panaccione, S Ghosh. Increased prevalence of novel IL-17 secreting Foxp3

expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory

cells support Th17-Treg plasticity in inflammatory bowel disease patients. Inflamm Bowel

Dis. 2013 Nov; 19(12):2522-34.

60. AW. Chan, G Munene, J Weaver, A MacLean, J Easaw, GG. Kaplan, RD. Parker, and E

Dixon. Cytoreductive Strategies in the Treatment of Carcinomatosis of Colorectal Origin:



22

Results of a Transdisciplinary National Survey. The Open Surgical Oncology Journal. 2013;

4: 1-6.

61. Jennifer CC deBruyn, Ing Shian Soon, James Hubbard, Iwona Wrobel, Remo Panaccione,

Gilaad G Kaplan. Nationwide temporal trends in incidence of hospitalization and surgical

intestinal resection in pediatric inflammatory bowel diseases in the United States from 1997

to 2009. Inflamm Bowel Dis. 2013 Oct; 19(11):2423-32. Epub 2013 August 23.

62. Lisa Kish, Saad Y. Salim, Naomi Hotte, Robert Tso, Caroline D. Ethier, Renaud Vincent,

Gilaad G. Kaplan, Herman Barkema, Karen Madsen. Environmental particulate matter

induces murine intestinal inflammatory responses and alters the gut microbiome. PLoS One.

2013 Apr 24; 8(4): e62220.

63. Kaplan GG*, Tanyingoh D, Dixon E, Johnson M, Wheeler AJ, Myers RP, Bertazzon S,

Saini V, Madsen K, Ghosh S, and Villeneuve PJ. Daily Changes in Ambient Ozone

Concentrations Associated with Increased Risk of Perforated Appendicitis: A Multi-City

Case Crossover Study. Environmental Health Perspectives. 2013 Aug; 121(8): 939-43. Epub

July 11 2013.

64. Moran GW, Dubeau MF, Kaplan GG, Panaccione R, Ghosh, S. The increasing weight of

Crohn’s disease subjects in clinical trials: a hypothesis-generating time-trend analysis.

Inflamm Bowel Dis. 2013 Dec; 19(13): 2949-56.

65. McColl RJ, Shaheen AA, Brar B, Kaplan G, Myers R, Sutherland F, Dixon E. Survival after

hepatic resection: impact of surgeon training on long-term outcome. Can J Surg. 2013 Aug;

56(4): 256-62.

66. Soon I, Butzner D, Kaplan GG, deBruyn J. Incidence and Prevalence of Eosinophilic

Esophagitis in Children: Systematic Review and Meta-Analysis. J Pediatr Gastroenterol

Nutr. 2013 Jul; 57(1): 72-80.

67. Frolkis A, Dieleman LA, Barkema HW, Panaccione R, Ghosh S, Fedorak R, Madsen K, and

Kaplan GG*. Environment and the Inflammatory Bowel Diseases. Can J Gastroenterol.

2013; 27(3): e18-24.

68. Kaplan GG*, Seow C, Ghosh S, Molodecky N, Rezaie A, Moran G, Proulx M, Hubbard JN,

MacLean A, Buie D, and Panaccione R. Decreasing Colectomy Rates for Ulcerative Colitis:

A Population-Based Time Trend Study. Am J Gastroenterol. 2012 Dec; 107(12): 1879-87.

Epub 2012 Nov 20.

69. Kaplan GG, Szyszkowicz M, Fichna J, Rowe BH, Porada E, Vincent R, Madsen K, Ghosh

S, and Storr M. Non-specific abdominal pain and air pollution: a novel association. PLoS

One. 2012; 7 (10): e47669. Epub 2012 Oct 31.


23

70. Kirsten M Fiest, Jonathan Dykeman, Scott B Patten, Samuel Wiebe, Gilaad G Kaplan,

Colleen J Maxwell, Andrew G.M. Bulloch, and Nathalie Jette. Depression in Epilepsy: A

Systematic Review & Meta-Analysis. Neurology. 2013 Feb 5; 80(6): 590-9. Epub 2012 Nov

21.

71. Ma C, Crespin M, Proulx MC, DeSilva S, Hubbard J, Prusinkiewicz M, Nguyen GC,

Panaccione R, Ghosh S, Myers RP, Quan H, and Kaplan GG*. Postoperative complications

following colectomy for ulcerative colitis: A validation study. BMC Gastroenterol. 2012 Apr

27; 12: 39.

72. RP Myers, JN Hubbard, AA Shaheen, E Dixon, GG Kaplan. Hospital performance reports

based on severity adjusted mortality rates in patients with cirrhosis depend on the method of

risk adjustment. Ann Hepatol. 2012 Jul; 11(4): 526-35.

73. S.M. Devlin, A.S. Cheifetz, C. Siegel, L. Baidoo, B. Bressler, L.E. Raffals, P.M. Irving, J.

Jones, G.G. Kaplan, P.L. Kozuch, G.Y. Melmed, M.P. Sparrow, F.S. Velayos. Patient-

specific approach to combination versus monotherapy with the use of antitumor necrosis

factor agents for inflammatory bowel disease. Gastroenterol Clin North Am. 2012 Jun; 41(2):

411-28. Epub 2012 Feb 14.

74. Soon IS, Molodecky N, Rabi DM, Ghali WA, Barkema HW, and Kaplan GG*. The

relationship between urban environment and IBD: a systematic review and meta-analysis.

BMC Gastroenterol. 2012 May 24; 12 (1): 51

75. Schicho R, Shaykhutdinov R, Ngo J, Nazyrova A, Schneider C, Panaccione R, Kaplan GG,

Vogel HJ, Storr M. Quantitative Metabolomic Profiling of Serum, Plasma, and Urine by (1)H

NMR Spectroscopy Discriminates between Patients with Inflammatory Bowel Disease and

Healthy Individuals. J Proteome Res. 2012 Jun 1; 11(6): 3344-57.

76. MF Dubeau, M Iacucci, PL Beck, GW Moran, GG Kaplan, S Ghosh, R Panaccione. Drug-

induced inflammatory bowel disease (IBD) and IBD-like conditions. Inflamm Bowel Dis.

2013 Feb; 19(2): 445-56. Epub 2012 May 9.

77. A. Cheifetz, G. Melmed, B. Spiegel, J. Talley, S. Devlin, L. Harrell, P. Irving, J. Jones, G.G.

Kaplan, P. Kozuch, M. Sparrow, F.S. Velayos, L. Baidoo, B. Bressler, C. Siegel. Setting

priorities for comparative effectiveness research in inflammatory bowel disease: results of an

international provider survey, expert rand panel, and patient focus groups. Inflamm Bowel

Dis. 2012 Dec; 18(12): 2294-300. Epub 2012 Feb 15.

78. Leung Y, Kaplan GG, King A, Kamhawi S, Stasiak S, Rioux K, and Rubin, D. Assessment

of variables associated with smoking cessation in Crohn's Disease. Digestive Diseases and

Sciences; 2012 Apr; 57(4): 1026-32.

79. I Soon, B Kaplan, M Proulx, I Wrobel, J deBruyn, and GG Kaplan*. Postoperative

Complications Following Colectomy for Ulcerative Colitis in Children: A Population-Based

Study. J Pediatr Gastroenterol Nutr. 2012 Jun; 54(6): 763-8. 2011. Epub 2012 Dec 12.



24

80. Molodecky N, Soon IS, Rabi D, Ghali W, Ferris M, Chernoff G, Benchimol E, Panaccione

R, Ghosh S, Barkema H, and Kaplan GG*. Increasing Incidence of Inflammatory Bowel

Disease with Time and Among Regions, Based on Systematic Review. Gastroenterol. 2012

Jan; 142(1): 46-54.

81. S de Silva, C Ma, M Proulx, M Crespin, BS Kaplan, J Hubbard, M Prusinkiewicz, A Fong, R

Panaccione, S Ghosh, PL Beck, A MacLean, D Buie, and GG Kaplan*. Postoperative

Complications and Mortality Following a Colectomy for Ulcerative Colitis. Clin

Gastroenterol Hepatol. 2011; 9(11): 972-80. Epub 2011 Jul 30.

82. Jan Grendar, Abdel A Shaheen, Robert P Myers, Robyn Parker, Charles M Vollmer Jr, Chad

G Ball, May Lynn Quan, Gilaad G Kaplan, Tariq Al-Manasra, Elijah Dixon. Predicting In-

Hospital Mortality in Patients Undergoing Complex Gastrointestinal Surgery: What Is The

Optimal Risk-Adjustment Methodology? Archives Surgery; 2012 Feb; 147(2): 126-135.

[Epub 2011 Oct 17].

83. Stephen E. Congly, Abdel Aziz M. Shaheen, Lisa Meddings, Gilaad G. Kaplan, and Robert

P. Myers. Amebic Liver Abscess in the United States: A Population-Based Study of

Incidence, Temporal Trends, and Mortality. Liver International. 2011 Sep; 31(8): 1191-8.

84. Strauss J, Kaplan GG, Beck PL, Rioux K, Panaccione R, Devinney R, Lynch T, Allen-

Vercoe E. Invasive potential of gut mucosa-derived fusobacterium nucleatum positively

correlates with IBD status of the host. Inflamm Bowel Dis. 2011; 17(9): 1971-8. Jan 13 [Epub

ahead of print]

85. deBruyn JC, Hilsden R, Fonseca K, Russell ML, Kaplan GG, Vanderkooi O, Wrobel I.

Immunogenicity and Safety of Influenza Vaccination in Children with Inflammatory Bowel

Disease. Inflamm Bowel Dis. 2012; Jan; 18(1): 25-33.

86. Molodecky NA, Kareemi H, Parab R, Barkema HW, Quan H, Myers RP, and *Kaplan GG.

The Incidence of Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis.

Hepatology. 2011; 53(5): 712-20.

87. Molodecky NA, Myers RP, Barkema HW, Quan H, and *Kaplan GG.Validity of

Administrative Data for the Diagnosis of Primary Sclerosing Cholangitis (PSC): A

Population-Based Study. Liver International. 2011; May; 31(5): 712-20.

88. Shale M, Czub M, Kaplan GG, Panaccione R, and Ghosh S. Anti-tumor necrosis factor

therapy & influenza: keeping it in perspective. Therap Adv Gastroenterol. 2010; 3(3): 173-7.

89. Szyszkowicz M, Eugeniusz Porada, Kaplan GG, Rowe BH. Ambient ozone and emergency

department visits for cellulitis. Int J Occup Med Environ Health. 2010; 7(11): 4078-88.


25

90. Molodecky NA, Panaccione R, Ghosh S, Barkema HW, *Kaplan GG. Challenges associated

with identifying the environmental determinants of the inflammatory bowel diseases.

Inflamm Bowel Dis. 2011; 17(8):1792-1799.

91. *Kaplan GG, Hubbard J, Panaccione R, Shaheen AM, Quan, H, Nguyen GC, Dixon E,

Ghosh S, and Myers RP. The risk of comorbidities on postoperative outcomes in

inflammatory bowel disease patients. Arch Surg. 2011; 146(8): 959-64.

92. Molodecky NA, *Kaplan GG. Environmental risk factors for inflammatory bowel disease.

Gastroenterol Hepatol (N.Y.). 2010; 6(5): 339-46.

93. *Kaplan GG, Hubbard JN, Korzenik J, Sands BE, Panaccione R, Ghosh S, Wheeler AJ, and

Villeneuve P. The Inflammatory Bowel Diseases and Ambient Air Pollution: A Novel

Association. Am J Gastroenteorol. 2010; 105(11): 2412-9. Jun 29 [Epub ahead of print].

94. Melmed GY, Spiegel BM, Bressler B, Cheifetz AS, Devlin SM, Harrell LE, Irving PM,

Jones J, Kaplan GG, Kozuch PL, Velayos FS, Baidoo L, Sparrow MP, and Siegel CA.

Appropriateness of concomitant immunomodulators with anti-TNF agents for Crohn’s

disease. Clin Gastroenterol Hepatol. 2010; 8(8): 655-9.

95. Meddings L, Myers RP, Shaheen AA, Laupland KB, Hubbard J, & *Kaplan GG. A

Population-Based Study of Pyogenic Liver Abscesses in the US: Incidence, Mortality, and

Temporal Trends. Am J Gastroenterol. 2010; 105(1): 117-204.

96. Shale M, Seow C, Coffin C, Kaplan GG, Panaccione R, and Ghosh S. Viral infections in the

anti-tumour necrosis factor therapy era in inflammatory bowel diseases. Aliment Pharmacol

Ther 2010; 31(1): 20-34.

97. Seow CH, de Silva S, Kaplan GG, Devlin SM, Ghosh S, Panaccione R. Managing the risks

of IBD therapy. Curr Gastroenterol Rep. 2009; 11(6): 509-17.

98. Szyszkowicz M, Kaplan GG, Grafstein E, Rowe BH. Emergency department visits for

migraine and headache: a multi-city study. Int J Occup Med Environ Health. 2009; 22(3):

235-42.

99. *Kaplan GG, Dixon E, Panaccione R, Fong A, Chen L, Szyszkowicz M, Wheeler A,

Heitman S, MacLean A, Buie D, Leung T, and Villeneuve P. Effect of ambient air pollution

on the incidence of appendicitis. CMAJ. 2009; 181(9): 591-7.

100. Ma C, Panaccione J, Heitman S, Devlin S, Ghosh S, and *Kaplan GG. Systematic

Review: Short and long-term efficacy of adalimumab following discontinuation of

infliximab. Aliment Pharmacol Ther 2009; 30(10): 977-86. Epub 2009 Jul 22.

101. Shale M, Kaplan GG, Panaccione R, and Ghosh S. Isotretinoin and intestinal

inflammation: what gastroenterologists need to know. Gut. 2009; 58(6):737-41.


26

102. Leung TW, Dixon E, Gill M, Mador BD, Moulton KM, Kaplan GG, Maclean AR.

Bowel Obstruction Following Appendectomy: What is the True Incidence? Annals of

Surgery. 2009; 250(1): 51-53.

103. Shaheen AA, Kaplan GG, Hubbard JN, and Myers RP. Morbidity and mortality

following coronary artery bypass graft surgery in patients with cirrhosis: a population-based

study. Liver Int. 2009; 29(8):1141-51.

104. Myers RP, Shaheen AA, Hubbard JN, Kaplan GG. Characteristics of Patients with

Cirrhosis Who are Discharged from Hospital Against Medical Advice. Clin Gastroenterol

Hepatol.2009; 7(7):786-92.

105. Szyszkowicz M, Rowe, BH, and Kaplan GG. Ambient Sulphur Dioxide Exposure and

Emergency Department Visits for Migraine in Vancouver, Canada. International Journal of

Medicine and Environmental Health. 2009; 22(1): 1-6.

106. Myers RP, Kaplan GG, Shaheen AA. The effect of weekend versus weekday admission

on outcomes of esophageal variceal hemorrhage. Can J Gastroenterol. 2009; 23(7): 495-501.

107. Nguyen GC, Sam J, Murthy SK, Kaplan GG, Tinmouth JM, and LaVeist TA.

Hospitalizations for Inflammatory Bowel Disease: Profile of the Uninsured in the United

States. Inflammatory Bowel Disease. 2009 15(5): 726-33.

108. *Kaplan GG, Panaccione P, Hubbard J, Nguyen GC, Shaheen AM, Ma C, Devlin SM, &

Myers RP. IBD Patients Who Leave Hospital Against Medical Advice: Predictors and

Temporal Trends. Inflamm Bowel Dis. 2009; 15(6): 845-851.

109. Myers RP, Hubbard JN, Shaheen AA, & Kaplan GG. Predicting in-hospital mortality in

patients with cirrhosis: Results differ across risk adjustment methods. Hepatology. 2008;

49(2):568-577.

110. Ghosh S, Kaplan G, Panaccione R. Granulocyte-monocyte apheresis in ulcerative colitis

– the end of the road? Nat Clin Proc Gastroenterol. 2009; 6(1):6-7.

111. Shaheen AA, Kaplan GG, Myers RP. Weekend versus weekday admission and mortality

from gastrointestinal hemorrhage due to peptic ulcer disease. Clin Gastroenterol Hepatol.

2009; 7(3):303-10.

112. *Kaplan GG, Jackson T, Sands BE, Frisch M, Andersson R, and Korzenik J. The risk of

developing Crohn’s disease after an appendectomy: A Meta-analysis. American Journal of

Gastroenterology. 2008; 103(11): 2925-31.

113. McColl RJ, You X, Ghali WA, Kaplan G, Myers RP, Dixon E. Recent trends of hepatic

resection in Canada: 1995-2004. J Gasto Surg. 2008; 12(11):1839-46.


27

114. DeSilva S, Kaplan G, Panaccione R. Sequential Therapies for Crohn’s disease:

Optimizing conventional and biologics strategies. Rev Gastroenterol Disord. 2008; 8(2):109-

16.

115. Myers RP, Papay KD, Shaheen AA, Kaplan GG. The relationship between hospital

volume and outcomes of esophageal variceal bleeding in the United States. Clin

Gastroenterol Hepatol. 2008; 6(7):789-98.

116. *Kaplan GG, McCarthy E, Ayanian J, Korzenik J, Hodin R, Sands BE. Impact of

Hospital Volume on Postoperative Morbidity and Mortality Following a Colectomy for

Ulcerative Colitis. Gastroenterology. 2008; 134(3):680-7.

117. Nguyen GC, Kaplan GG, Harris ML, & Brant SR. A National Survey of the Prevalence

and Impact of Clostridium Difficile Infection Among Hospitalized IBD Patients. Am J

Gastroenterol. 2008; 103(6): 1443-50.

118. Kaplan GG, Hur C, Korzenik J, and Sands BE. Infliximab dose escalation versus

initiation of adalimumab for loss of response in Crohn’s disease: A cost-effectiveness

analysis. Alimentary Pharmacologic Therapeutics. 2007; 26(11): 1509-1520. Epub 2007 Oct

11.

119. Kaplan GG, Seminowich S, Williams J, Muruve D, Dupre M, Urbanski SJ, Yilmaz S,

Burak KW, Beck PL. The Risk of Microscopic Colitis in Solid Organ Transplantation

Patients: A Population Based Study. Transplantation. 2008; 85(1):48-54.

120. Williams JJ**, Kaplan GG**, Makhija S, Urbanski SJ, Dupre M, Panaccione R, and

Beck PL. Microscopic Colitis - Defining Incidence Rates and Risk Factors: A Population-

Based Study. Clin Gastroenterol Hepatol. 2008; 6(1): 35-40. **Co-first author.

121. Yan BM, Kaplan GG, Urbanski S, Nash CL, and Beck PL. Epidemiology of

gastrointestinal stromal tumors (GIST) in a defined Canadian health region: a population-

based study. Int J Surg Pathol. 2008; 16(3):241-50.

122. Kaplan GG, Heitman S, Hilsden R, Urbanski S, Myers R, Lee SS, and Panaccione R. A

population-based assessment of the surveillance practice of colonic dysplasia in primary

sclerosing cholangitis. Inflamm. Bowel Dis. 2007; 13(11): 1401-1407.

123. Kaplan GG, Pedersen BV, Andersson RE, Sands BE, Korzenik J, Frisch M. The risk of

developing Crohn’s disease after an appendectomy: a population-based cohort study in

Sweden and Denmark. Gut. 2007; 56(10): 1387-1392.

124. Sands BE & Kaplan GG. The Role of TNF in Ulcerative Colitis. J Clinical Pharmacol.

2007; 47(8): 930-41.


28

125. Jackson TD, Kaplan GG, Arena G, Page J, Rogers SO. Laparoscopic versus open

resection for colorectal cancer: a meta-analysis of oncologic outcomes. J Am Coll Surg.

2007; 204(3): 439-46.

126. Kaplan GG, Laupland KB, Butzner D, Urbanski SJ, Lee SS. The burden of large and

small duct primary sclerosing cholangitis in adults and children: a population-based analysis.

Am J Gastroenterol. 2007; 102:1-8.

127. Kaplan GG, Bates D, McDonald D, Panaccione R, Romagnuolo J. Inappropriate use of

intravenous pantoprazole: extent of the problem and successful solutions. Clin Gastroenterol

Hepato. 2005; 3(12): 1207-1214.

128. Kaplan GG, Medlicott S, Culleton B and Laupland KB. Acute hepatic failure and multi-

system organ failurea secondary to replacement of the liver with metastatic melanoma. BMC

Cancer. 2005; 5: 67.

129. Kaplan GG, Manns B, and McLaughlin K. Heparin induced thrombocytopenia

secondary to intraperitoneal heparin exposure. Nephrology Dialysis Transplantation. 2005;

20(11): 2561-2562.

130. Kaplan GG, Gregson D, Laupland K. Population-based study of the epidemiology of

and the risk factors for pyogenic liver abscess. Clin Gastroenterol Hepatol. 2004; 2(11):

1032-1038.

Non-Peer Reviewed Manuscripts and Editorials

1. Kaplan GG*. Editorial: Smoking Cessation for Crohn’s Disease: Clearing the Haze. Am J

Gastroenterol. 2016 In press.

2. Kaplan GG*, Jess T. The Changing Landscape of IBD: East Meets West. Gastroenterology.

2016 Jan;150(1):24-6.

3. JA Hirota, C Carlsten1, M Sadatsafavi1, G Kaplan and SA Hirota. Airway diseases and

inflammatory bowel diseases: is it something in the air (pollution)? European Respiratory

Journal. July 2015. 46; (1): 287-288.

4. GG Kaplan*. Editorial - The pitfalls and perils of using administrative databases to evaluate

the incidence of IBD overtime. Inflamm Bowel Dis. 2014 Oct; 20(10):1777-9.

5. Kaplan GG*. Editorial: Does consuming the recommended daily level of fiber prevent

Crohn’s disease? Gastroenterology. 2013 Nov; 145(5): 925-927.

6. Kaplan G*. Editorial: Air Pollution and the Inflammatory Bowel Diseases. Inflamm Bowel

Dis. 2011 May; 17(5):1146-8.



29

7. Kaplan G*. Editorial: Age Distribution of IBD Hospitalization. Inflamm Bowel Dis. 2010.

16(3): 458-60.

8. Kaplan GG*. Editorial: Administrative Database Studies in IBD: A Cautionary Tale. Am J

Gastroenterol. 2010; 105(8): 1808-10.

9. Kaplan GG, Molodecky N, Panaccione R. Environmental triggers of the inflammatory

bowel diseases. IBD Monitor. 2011; 11(2): 1 to 5.

10. Kaplan GG, Hur C, Korzenik J, and Sands BE. Infliximab vs Adalimumab for Crohn’s

disease: authors’ reply. Alimentary Pharmacologic Therapeutics. 2008; 28(10): 1266-1267.

11. Kaplan GG and Panaccione R. Use of combination therapy in IBD. Inflammatory Bowel

Disease.2008; 14(S2):S219-S221.

12. Kaplan GG and Panaccione R. Selected Summary: The anti TNF race. The caution flag is

raised again. Inflammatory Bowel Disease. 2004; 10:61-62.

13. Kaplan GG and Manns B. Renal regulation: The keys to preventing chronic renal failure.

Canadian Journal of Continuing Medical Education. 2003; 15(2): 55-64.

14. Kaplan GG, Bates D, McDonald D, Romagnuolo J. Inappropriate prescribing leading to

rapidly escalating costs of IV proton pump inhibitors in the Calgary Health Region. Pharma

News 2002; 26(3): 1-4.

15. Mellor J and Kaplan GG. Is it asthma or not? A plea for more objectivity. Canadian Journal

of Continuing Medical Education. 2000; 12(9):41-49.

Book Chapters

1. Soon I.S., Kaplan GG. Travelling with IBD. In: Irving P., Siegel C., Rampton D., Shanahan

F. (eds), Clinical Dilemmas in IBD 2. Oxford: Blackwell Publishing Ltd, 2011.

2. Barkema HW, Hendrick S, De Buck JM, Ghosh S, Kaplan GG, and Rioux K. Crohn’s

Disease in Humans and Johne’s Disease in Cattle – Linked Diseases? In: Krause D (ed),

Zoonotic Pathogens in the Food Chain.

Abstracts (Trainees Underlined)

1. Gil Melmed, Peter Irving, David T. Rubin, Jennifer Soares, Brennan Spiegel, Laura Raffals,

Miles Sparrow, Fernando Velayos, Leonard Baidoo, Brian Bressler, Adam Cheifetz, Shane

Devlin, Jennifer Jones, Gilaad Kaplan, Patricia Kozuch, Corey A. Siegel. Positioning

Treatments for Ulcerative Colitis: A RAND Appropriateness Panel. Am J Gastroenterol 2015

October; 110: S818.


30

2. Stephanie Coward, Fiona Clement, Tyler Williamson, Glen Hazlewood, Siew Ng, Steven

Heitman, Cynthia Seow, Remo Panaccione, Subrata Ghosh, and Gilaad Kaplan. The Rising

Burden of Inflammatory Bowel Disease in North America from 2015 to 2025: A Predictive

Model. Am J Gastroenterol 2015 October; 110: S829.

3. Gilaad Kaplan, Laura Raffals, Gil Melmed, Christina Ha, Jennifer Greene, Patricia Kozuch,

Miles Sparrow, Fernando Velayos, Leonard Baidoo, Brian Bressler, Adam Cheifetz, Shane

Devlin, Peter Irving, MD, Jennifer Jones, MD, Brennan Spiegel, Corey Siegel. Excellent

Inter-observer Agreement Between a Web-based Self-Report Questionnaire and Medical

Chart Review for the Management of Inflammatory Bowel Disease. Am J Gastroenterol

2015 October; 110: S835.

4. Ellen Kuenzig, Bertus Eksteen, Herman W. Barkema, Cynthia Seow, Mark Silverberg,

Richard Fedorak, Levinus Dieleman, Remo Panaccione, Subrata Ghosh, and Gilaad G.

Kaplan. Age at Diagnosis of Crohn’s Disease may Explain NOD2-Smoking Interactions. Am

J Gastroenterol 2015 October; 110: S837.

5. Ellen Kuenzig, Bertus Eksteen, Herman W. Barkema, Cynthia Seow, Cheryl Barnabe, Mark

Silverberg, Peter Lakatos, Remo Panaccione, Subrata Ghosh, and Gilaad G. Kaplan. The

Interaction Between NOD2 and Smoking is Specific to the 1007fs SNP of the NOD2 Gene in

Crohn’s Disease: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2015

October; 110: S838.

6. Kuenzig E, Barkema HW, Eksteen B, Seow C, Barnabe C, Silverberg M, Beck PL, Fedorak

R, Dieleman L, Madsen K, MacNaughton W, Panaccione R, Ghosh S, Kaplan GG. Patients

with Crohn’s disease who never smoke are more likely to carry NOD2 variants: A case-only

NOD2-smoking interaction study. Gastrotenterology, 2015;148(4):S474.

7. Stephanie Coward, Ellen Kuenzig, Glen Hazlewood, Rebecca Holmes, Remo Panaccione,

Subrata Ghosh, Cynthia Seow, Ali Rezaie, Gilaad G. Kaplan. The comparative efficacy of

induction of remission for mesalamine, sulfasalazine, and budesonide for the treatment of

mild to moderate Crohn’s disease: A Bayesian network meta-analysis. Gastroenterology.

2015; 148(4): S271.

8. Samuel Quan, Mollie C. Ferris, Divine Tanyingoh, Belle Kaplan, Natalie A. Molodecky,

Robert P. Myers, Chad G. Ball, Gregory W. Chernoff, Subrata Ghosh, Elijah Dixon, Gilaad

Kaplan. The Global Incidence of Appendicitis: A Population-Based North American Cohort

Study and Systematic Review. Gastrotenterology, 2015;148(4):S789-90.

9. Marietta Iacucci, Miriam Fort Gasia, Remo Panaccione, Gilaad Kaplan, Subrata Ghosh,

Xianyong Gui. Endoscopic Assessment of Mucosal Healing in Crohn's Disease by Novel

iSCAN Endoscopic and Refined Histological Gradings. Gastrotenterology,

2015;148(4):S638.

10. Miriam Fort Gasia, Xianyong Gui, Remo Panaccione, Gilaad Kaplan, Subrata Ghosh,


31

Marietta Iacucci. Clinical Outcome of Ulcerative Colitis Patients With Complete Mucosal

Healing but With Subtle Abnormalities Detected by Novel iSCAN Endoscopic.

Gastrotenterology, 2015;148(4):S826.

11. Michael J. Stewart, Ahmed Al-Darmaki, Remo Panaccione, Gilaad Kaplan, Cynthia H.

Seow. Biologic Therapies Are Effective in Inducing and Maintaining Mucosal Healing in

Ulcerative Colitis: A Systematic Review & Meta-Analysis. Gastrotenterology,

2015;148(4):S271.

12. Marietta Iacucci, Miriam Fort Gasia, Stefan J. Urbanski, Minoo Parham, Gilaad Kaplan,

Remo Panaccione, Subrata Ghosh. A Randomized Comparison of High Definition

Colonoscopy Alone With High Definition Dye Spraying and Electronic Virtual

Chromoendoscopy Using iSCAN for Detection of Colonic Dysplastic Lesions During IBD

Surveillance Colonoscopy. Gastrotenterology, 2015;148(4):S74.

13. Ahmed Al-Darmaki, James N. Hubbard, Cynthia H. Seow, Yvette Leung, Kerri L. Novak,

Subrata Ghosh, Remo Panaccione, Gilaad Kaplan. Predictors of 3-Year Risk of Colectomy

Among Hospitalized Patients With Ulcerative Colitis: A Population-Based Study.

Gastrotenterology, 2015;148(4):S255.

14. Laura Targownik, Geoffrey C. Nguyen, Amy Metcalfe, Eric I. Benchimol, Jennifer L. Jones,

Gilaad Kaplan, Greg Rosenfeld, Zoann Nugent, Yvette Leung, Cynthia H. Seow, Mindy

Ching Wan Lam. Pregnancy and Birth Rates Are Decreased Among Women With IBD:

Results of a Canadian Population-Based Cohort Study. Gastrotenterology,

2015;148(4):S470.

15. Humberto Jijon, Aito Ueno, Suzanne Traves, Ronald Chan, Miriam Fort Gasia, Divine

Tanyingoh, Paul L. Beck, Gilaad Kaplan, Remo Panaccione, Marietta Iacucci, David Proud,

Subrata Ghosh. Cigarette Smoke Extract Differentially Affects Expression of CD11c in

Monocyte-Derived Dendritic Cells in Crohn's Disease Patients With Active Versus Inactive

Disease. Gastrotenterology, 2015;148(4):S441.

16. Samuel Quan, Hong Yang, Robert J. Hilsden, Karen Madsen, Sander Veldhuyzen van

Zanten, Kerri L. Novak, Eddy Lang, Subrata Ghosh, Gilaad Kaplan. Acute Air Pollution

Exposure Is Not Associated With Upper Gastrointestinal Bleeding Secondary to Peptic Ulcer

Disease: A Case-Crossover Study. Gastrotenterology, 2015;148(4):S222.

17. Alex Frolkis, Jennifer deBruyn, Nathalie Jette, Mark W. Lowerison, Jordan Engbers, James

Lewis, Isabelle A. Vallerand, Scott Patten, Bertus Eksteen, Cheryl Barnabe, Remo

Panaccione, Subrata Ghosh, Samuel Wiebe, Gilaad Kaplan. The Age Dependent Effect of

Smoking on the Risk of Surgery for the Inflammatory Bowel Diseases. Gastrotenterology,

2015;148(4):S470.

18. Maria Negron, Herman W. Barkema, Ali Rezaie, Kevin P. Rioux, Jeroen De Buck, Sylvia

Checkley, Paul L. Beck, Matthew W. Carroll, Richard N. Fedorak, Levinus A. Dieleman,

Remo Panaccione, Subrata Ghosh, Gilaad Kaplan. Early Detection of Clostridium difficile


32

Infection Impacts Disease Related Outcomes in Patients With Ulcerative Colitis Patients: A

Population-Based Inception Cohort Study. Gastrotenterology, 2015;148(4):S465.

19. Eric I. Benchimol, Gilaad Kaplan, Geoffrey C. Nguyen, Jennifer L. Jones, Astrid Guttmann,

Beth K. Potter, Christina A. Catley, Fox E. Underwood, Zoann Nugent, Laura Targownik,

Desmond Leddin, Anthony R. Otley, Charles N. Bernstein. The Influence of Rural/Urban

Environment on the Risk of Inflammatory Bowel Disease in Canada: A Population-Based

and Birth Cohort Study From the Canadian Gastro-Intestinal Epidemiology Consortium

(CanGIEC). Gastrotenterology, 2015;148(4):S3.

20. A Frolkis, J deBruyn, N Jette, M Lowerison, I Vallerand, S Patten, B Eksteen, C Barnabe, R

Panaccione, S Ghosh, S Wiebe, G Kaplan. Smoking’s influence on the risk of surgery for the

inflammatory bowel diseases is dependent on age at diagnosis. Can J Gastroenterol

Hepatology. 2015; 29 (SA): A004.

21. S Coward, H Kareemi, F Clement, J Hubbard, M Proulx, E Dixon, C Ball, S Heitman, R

Myers, M Swain, S Ghosh, G Kaplan. Incidence of appendicitis over time: a comparative

analysis of an administrative healthcare database and a pathology-proven appendicitis

registry. Can J Gastroenterol Hepatology. 2015; 29 (SA): A073.

22. A Shaheen, R Myers, G Kaplan. The impact of weekend versus weekday admission on

outcomes of the inflammatory bowel diseases: a population-based study. Can J

Gastroenterol Hepatology. 2015; 29 (SA): A074.

23. M Stewart, A Al-Darmaki, R Panaccione, G Kaplan, C Seow. Biologic therapies are effective

in inducing and maintaining mucosal healing in ulcerative colitis: a systematic review &

meta-analysis. Can J Gastroenterol Hepatology. 2015; 29 (SA): A118.

24. M Iacucci, M Fort Gasia, S Urbanski, X Gui, G Eustace, G Kaplan, R Panaccione, S Ghosh.

Detection of sessile serrated adenomas during surveillance colonoscopy in IBD patients by

dye spraying chromoendoscopy and by electronic virtual chromoendoscopy. Can J


25. A Shaheen, G Kaplan, K Burak, M Swain, R Myers. The impact of nursing volume on

hospitalization outcomes among patients with cirrhosis: a population-based study. Can J


26. D Jacob, G Kaplan, R Panaccione, S Ghosh, E Ehteshami-Afshar, K Novak. Accuracy of

gastroenterologist performed point of care ultrasound in patients with irritable bowel

syndrome - diarrhea predominant. Can J Gastroenterol Hepatology. 2015; 29 (SA): A038.

27. S Quan, M Ferris, D Tanyingoh, B Kaplan, N Molodecky, R Myers, C Ball, G Chernoff, S

Ghosh, E Dixon, G Kaplan. The global burden of appendicitis: a population-based north

http://www.pulsus.com/abstracts/index.jsp?id=5&jnlKy=2#/abstract/1397




33

american cohort study and systematic review. Can J Gastroenterol Hepatology. 2015; 29

(SA): A070.

28. A Shaheen, R Myers, G Kaplan. Is nurse staffing associated with hospitalization outcomes in

inflammatory bowel disease? Can J Gastroenterol Hepatology. 2015; 29 (SA): A081.

29. J Pang, E Ross, M Borman, S Zimmer, G Kaplan, S Heitman, M Swain, K Burak, H Quan, R

Myers. Risk factors for mortality in patients with alcoholic hepatitis and assessment of

prognostic models: a population-based study. Can J Gastroenterol Hepatology. 2015; 29

(SA): A234.

30. S Quan, H Yang, D Tanyingoh, R Hilsden, K Madsen, S Veldhuyzen van Zanten, K Novak,

E Lang, S Ghosh, G Kaplan. Short-term increases in air pollution are not associated with the

incidence of upper gastrointestinal bleeding secondary to peptic ulcer disease: a case-

crossover study. Can J Gastroenterol Hepatology. 2015; 29 (SA): A089.

31. A Al-Darmaki, J Hubbard, C Seow, Y Leung, K Novak, S Ghosh, R Panaccione, G Kaplan.

Clinical predictors of 3-year risk of colectomy in ulcerative colitis: a population-based study.

Can J Gastroenterol Hepatology. 2015; 29 (SA): A117.

32. Y Leung, G Kaplan, E Ehteshami-Afshar, D Tanyingoh, H Barkema, S Ghosh, R

Panaccione, C Seow. CRP does not correlate with disease activity in pregnant women with

IBD. Can J Gastroenterol Hepatology. 2015; 29 (SA): A124.

33. M Iacucci, M Fort Gasia, R Panaccione, G Kaplan, S Ghosh, X Gui. Residual mucosal

abnormalities after mayo endoscopic subscore defined complete mucosal healing

demonstrated by iscan endoscopic and refined new histologic gradings. Can J Gastroenterol


34. A Kellar, G Kaplan, R Panaccione, J deBruyn, S Wilson, D Tanyingoh, K Novak. A simple

ultrasound score for pediatric crohn’s disease - a retrospective analysis. Can J Gastroenterol


35. S Singh, A Al-Darmaki, A Frolkis, C Seow, Y Leung, K Novak, S Ghosh, R Panaccione, GG

Kaplan*. Post-operative mortality for the inflammatory bowel diseases: a systematic review

and meta-analysis of population-based studies. Gastroenterol. 2014; 146(5 Suppl 1): S200.

36. Shane M. Devlin, Gil Y. Melmed, Peter M. Irving, David T. Rubin, Asher Kornbluth,

Patricia L. Kozuch, Laura H. Raffals, Fernando S. Velayos, Miles Sparrow, Leonard Baidoo,

Brian Bressler, Adam S. Cheifetz, Jennifer Jones, Gilaad Kaplan, Jennifer Greene, Corey A.

Siegel. Recommendations for Creating a High Quality Endoscopy Report for Inflammatory

Bowel Disease Patients: Results from a RAND-Appropriateness Panel. Gastroenterol. 2014;

146(5 Suppl 1): S188.


34

37. M Negron, H Barkema, A Frolkis, S Checkley, K Rioux, J De Buck, R Panaccione, S Ghosh,

G Kaplan*. Temporal changes in colectomy rates due to colorectal neoplasia among UC

patients: a population based cohort. Can J Gastroenterol. 2014; 28 (SA): A7.

38. A Frolkis, D Lipton, M Negron, K Fiest, J Dykeman, J deBruyn, N Jette, G Kaplan*.

Recurrent intestinal resections for Crohn's disease have decreased over time: a systematic

review and meta-analysis of population-based studies. Can J Gastroenterol. 2014; 28 (SA):

A98.

39. A Frolkis, G Kaplan, A Patel, P Faris, H Quan, N Jette, J deBruyn. Short-term readmission

and postoperative complications in Crohn's disease and ulcerative colitis patients - a

province-wide cohort study. Can J Gastroenterol. 2014; 28 (SA): A100.

40. M Negron, G Kaplan, H Barkema, B Eksteen, F Clement, B Manns, S Coward, S Heitman.

Colorectal neoplasia surveillance in patients with inflammatory bowel disease and primary

sclerosing cholangitis: an economic evaluation. Can J Gastroenterol. 2014; 28 (SA): A247.

41. D Kevans, A Tyler, K Holm, K Jørgensen, M Vatn, B Eksteen, G Kaplan, T Karlsen, D

Gevers, J Hov, M Silverberg. Characterization of the intestinal microbiota in ulcerative

colitis patients with and without primary sclerosing cholangitis. Can J Gastroenterol. 2014;

28 (SA): A145.

42. S Coward, S Heitman, F Clement, M Negron, R Panaccione, S Ghosh, H Barkema, C Seow,

Y Leung, G Kaplan*. A cost-utility analysis of funding smoking cessation programs for

patients with Crohn's disease. Can J Gastroenterol. 2014; 28 (SA): A149.

43. Y Leung, G Kaplan, S Coward, D Tanyingoh, S Ghosh, R Panaccione, C Seow. Surgery for

IBD associated with a poor prognosis for pregnancies in women with IBD. Can J

Gastroenterol. 2014; 28 (SA): A152.

44. K Novak, D Jacob, R Panaccione, G Kaplan, J Heatherington, Y Leung. Accuracy of

gastroenterologist performed point of care ultrasound for detection of inflammation and

complications in patients with inflammatory bowel disease. Can J Gastroenterol. 2014; 28

(SA): A160.

45. S Singh, A Al-Darmaki, A Frolkis, C Seow, Y Leung, S Ghosh, R Panaccione, G Kaplan*.

Post-operative mortality in ulcerative colitis: a systematic review of population-based

studies. Can J Gastroenterol. 2014; 28 (SA): A257.

46. A Al-Darmaki, S Singh, A Frolkis, C Seow, Y Leung, S Ghosh, R Panaccione, G Kaplan*.

Post-operative mortality in Crohn’s disease: a systematic review of population-based studies.

Can J Gastroenterol. 2014; 28 (SA): A270.

47. M Diamant, S Schaffer, S Coward, E Kuenzig, J Hubbard, M Proulx, A Sevo, R Panaccione,

S Ghosh, G Kaplan*. Smoking increases the risk for surgery in diverticulitis. Can J

Gastroenterol. 2014; 28 (SA): A194.


35

48. Laura Stinton, Gilaad Kaplan, Michael Mahler, Remo Panaccione, Subrata Ghosh, Marvin

Fritzler. Proteinase 3 (PR3) Autoantibodies as a Serological Marker in Inflammatory Bowel

Disease. Am J Gastroenterol. 2013 Oct;108; Suppl 1: S523.

49. Stephanie Coward, Steven Heitman, Fiona Clement, Maria Negron, Remo Panaccione,

Subrata Ghosh, Herman Barkema, Cynthia Seow, Yvette Leung, Gilaad Kaplan*. A Cost–

Utility Analysis of Smoking Cessation Programs for Patients with Crohn’s Disease. Am J

Gastroenterol. 2013 Oct;108; Suppl 1: S525.

50. Alexandra Frolkis, Debra Lipton, Maria Negron, Jonathan Dyekamn, Kirsten Fiest, Jennifer

deBruyn, Nathalie Jette, Remo Panaccione, Subrata Ghosh, Gilaad Kaplan*. Cumulative

Incidence of Second Major Abdominal Surgery Crohn’s Disease: A Systematic Review and

Meta-analysis of Population-based Studies. Am J Gastroenterol. 2013 Oct;108; Suppl 1:

S525.

51. Ali Rezaie, Glen Hazlewood, Remo Panaccione, Subrata Ghosh, Cynthia Seow, Ellen

Kuenzig, Corey Siegel, Gilaad Kaplan*. The Comparative Efficacy of Remission

Maintenance Therapy in Crohn’s Disease: A Bayesian Network Meta-analysis. Am J

Gastroenterol. 2013 Oct;108; Suppl 1: S535.

52. Ellen Kuenzig, Isabelle Vallerand, Ali Rezaie, Remo Panaccione, Cynthia Seow, Yvette

Leung, Steven Heitman, Subrata Ghosh, Gilaad Kaplan*. Induction Treatment with Anti-

TNF Decreases C-Reactive Protein Levels among Crohn’s Disease Patients: A Systematic

Review and Meta-analysis. Am J Gastroenterol. 2013 Oct;108; Suppl 1: S540.

53. Meena Mathivanan, Cynthia H. Seow, Gilaad G. Kaplan, Marie-Claude Proulx, Divine

Tanyingoh, Remo Panaccione, Subrata Ghosh, Yvette Leung. Peripartum Complications and

Assisted Conception in Crohn's Disease Patients Post Bowel Surgery: A Population-Based

Study. Gastroenterol. 2013; 144(5 Suppl 1): S-620.

54. Aito Ueno, Humberto Jijon, Suzanne Traves, Kim Ford, Ronald Chan, Paul L. Beck, Herman

Barkema, Remo Panaccione, David Proud, Gilaad G. Kaplan, Subrata Ghosh. Cigarette

Smoke Extract Decreases Regulatory T-Cells and Increases IFN-Gamma Secreting T-Cells in

Peripheral Blood From Crohn's Disease Compared to Ulcerative Colitis Patients: Differential

Smoking Effects on Two Types of Inflammatory Bowel Disease. Gastroenterol. 2013; 144(5

Suppl 1): S-303.

55. Marietta Iacucci, XSean Gui, Remo Panaccione, Gilaad G. Kaplan, Mark G. Swain,

Jonathan R. Love, Subrata Ghosh, Bertus Eksteen. Colonic Confocal Laser Endomicroscopy

Findings in Patients With Primary Sclerosing Cholangitis. Gastroenterol. 2013; 144(5 Suppl

1): S-890.

56. Robert Tso, Patrick M. Gillevet, Russ Greiner, Levinus A. Dieleman, Kevin P. Rioux,

Gilaad G. Kaplan, Herman Barkema, Petya Koleva, Rosica Valcheva, Ellen Kuenzig, Karen

Kroeker, Richard N. Fedorak, Karen Madsen. Distinctive Urinary Metabolite Profiles


36

Correlate With Microbial Composition and Are Linked With Endoscopic Post-Operative

Disease Recurrence in Crohn's Disease Patients. Gastroenterol. 2013; 144(5 Suppl 1): S-193.

57. Jennifer Jones, Gilaad G. Kaplan, Laurent Peyrin-Biroulet, Leonard Baidoo, Shane Devlin,

Gil Y. Melmed, Divine Tanyingoh, Laura H. Raffals, Peter M. Irving, Patricia L. Kozuch,

Miles Sparrow, Fernando S. Velayos, Brian Bressler, Adam S. Cheifetz, Jean-Frederic

Colombel, Corey A. Siegel. Impact of Concomitant Immunomodulator Treatment on

Efficacy and Safety of Anti-TNF Therapy in Crohn's Disease: A Meta-Analysis of Placebo

Controlled Trials With Individual Patient-Level Data. Gastroenterol. 2013; 144(5 Suppl 1):

S-179.

58. Ellen Kuenzig, Isabelle A. Vallerand, Remo Panaccione, Cynthia H. Seow, Yvette Leung,

Steven J. Heitman, Subrata Ghosh, Gilaad G. Kaplan*. Treatment of Crohn's Disease With

Anti-Tumor Necrosis Factor Decreases Levels of C-Reactive Protein: A Systematic Review

and Meta-Analysis. Gastroenterol. 2013; 144(5 Suppl 1): S-218.

59. Matthew D. Sadler, Divine Tanyingoh, Robert P. Myers, Paul L. Beck, Steven J. Heitman,

Subrata Ghosh, Gilaad G. Kaplan. Incidence and Mortality of Ischemic Colitis: A

Population-Based Study. Gastroenterol. 2013; 144(5 Suppl 1): S-901.

60. Saad Y. Salim, Gilaad G. Kaplan, Herman Barkema, Eytan Wine, Karen Madsen. Early

Exposure to Airborne Particulate Matter Alters Intestinal Immune Function and Bacterial

Handling in IL-10 Deficient Mice. Gastroenterol. 2013; 144(5 Suppl 1): S-100.

61. Kaplan GG*, Tanyingoh D, Dixon E, Johnson M, Wheeler AJ, Myers RP, Bertazzon S,

Saini V, Madsen K, Ghosh S, and Villeneuve PJ. Daily Changes in Ambient Ozone

Concentrations Increases the Risk of Perforated Appendicitis. Gut. 2012; 61 (Suppl 3): A51.

62. Brown C, Gibson P, Stokes L, Hart A, Kaplan GG, Hautamaki E, Flood E, Beusterien K,

Fan T. Multi-National Long-Term Impacts of Colectomy Surgery Among Ulcerative Colitis

Patients Study (Locus). Gut. 2012; 61 (Suppl 3): A386.

63. Gilaad G. Kaplan, Gordon W. Moran, Alexandra Frolkis, Kevin P. Rioux, Subrata Ghosh,

Remo Panaccione. Surgical Rates Have Decreased for Emergent Crohn's Disease Resections

While Increasing for Elective Resections: A Population-Based Time Trend Study.

Gastroenterol. 2012; 142(5 Suppl 1): S-798.

64. Alexandra D. Frolkis, Jonathan Dykeman, Maria E. Negron, Jennifer deBruyn, Nathalie

Jette, Kevin P. Rioux, Remo Panaccione, Subrata Ghosh, Herman Barkema, Gilaad G.

Kaplan. Cumulative Incidence of First Intestinal Surgery in Adult and Pediatric Crohn's

Disease: A Systematic Review and Meta-Analysis. Gastroenterol. 2012; 142(5 Suppl 1): S-

790.

65. Aito Ueno, Humberto Jijon, Victor Lam, Karen K. Poon, Christina L. Hirota, Kim Ford, Ida

Rabbani, Gilaad G. Kaplan, Remo Panaccione, Paul L. Beck, Herman Barkema, David L.

Sigalet, Subrata Ghosh. Decreased TGF-β1 Secretion From Monocyte-Derived Dendritic


37

Cells is Associated With Higher Frequency of IL-17 Secreting FOXP3+ CD4+ T Cells in

Peripheral Blood From Inflammatory Bowel Disease Patients. Gastroenterol. 2012; 142(5

Suppl 1): S-348.

66. Lisa Kish, Saad Y. Salim, Naomi Hotte, Robert Tso, Caroline D. Ethier, Renaud Vincent,

Gilaad G. Kaplan, Herman Barkema, Karen Madsen. Airborne Particulate Matter Alters

Intestinal Permeability and Immune Function Through Direct Effects on Innate Immune

Cells. Gastroenterol. 2012; 142(5 Suppl 1): S-807.

67. Chad G. Ball, Elijah Dixon, Anthony R. MacLean, May Lynn Quan, Gilaad G. Kaplan,

Francis R. Sutherland. The Impact of a Dedicated Acute Care Surgery Clinical Care Pathway

for Suspected Appendicitis on Diagnostic Imaging and Flow Through the Emergency

Department. Gastroenterol. 2012; 142(5 Suppl 1): S-1051.

68. Jennifer deBruyn, Ing Shian Soon, James N. Hubbard, Iwona T. Wrobel, Gilaad G. Kaplan.

Stable Surgical Intestinal Resection Rates in Children With Inflammatory Bowel Diseases In

Spite of Rising Hospitalization Rates in the United States (1997-2009). Gastroenterol. 2012;

142(5 Suppl 1): S-789.

69. Michael J. Diamant, William D. Buie, Anthony R. MacLean, Elijah Dixon, Chad G. Ball,

Marie-Claude Proulx, Gilaad G. Kaplan. The Effect of Hospital Volume on in-Hospital

Mortality Among Diverticulitis Patients - a Nationwide Analysis. Gastroenterol. 2012; 142(5

Suppl 1): S-572.

70. Gordon W. Moran, Marie-France Dubeau, Gilaad G. Kaplan, Hong Yang, Cynthia H.

Seow, Shane Devlin, Levinus A. Dieleman, Richard N. Fedorak, Herman Barkema, Subrata

Ghosh, Remo Panaccione. Fibrostenotic Disease Behavior at the Onset of Biologic Therapy

is a Predictor of Poor Outcomes. Gastroenterol. 2012; 142(5 Suppl 1): S-258.

71. Marie-France Dubeau, Gordon W. Moran, Gilaad G. Kaplan, Hong Yang, Cynthia H.

Seow, Shane Devlin, Levinus A. Dieleman, Richard N. Fedorak, Herman Barkema, Subrata

Ghosh, Remo Panaccione. Use of Azathioprine in a Cohort of Crohn's Disease Patients on

Anti-TNF Drugs and Related Surgical Outcomes. Gastroenterol. 2012; 142(5 Suppl 1): S-

784.

72. Moran GW; Kaplan, GG; Yang H; Seow C; Devlin S; Dieleman LA; Fedorak RN; Ghosh S;

Panaccione R. Surgical Rates in Crohn’s disease patients treated with anti-TNF therapy are

related to disease phenotypes. Can J Gastroenterol. 2012; 26 (SA): A149.

73. Meddings L, Panaccione R, Yang H, Rioux K, MacLean A, Buie D, Frolkis A, Moran GW,

Ghosh S, and Kaplan GG*. Surgical Rates Have Decreased for Emergent Crohn’s Disease

Resections while Increasing for Elective Resections: A Population-Based Time Trend Study.

Can J Gastroenterol. 2012; 26 (SA): A242

74. Mathivanan, F Ladak, M Antón, GG Kaplan, R Myers. The incidence of primary biliary

cirrhosis: a systematic review and meta-analysis. Can J Gastroenterol. 2012; 26 (SA): A217.


38

75. S Taylor, S Coward, A Frolkis, M Proulx, S Quan, R Panaccione, B Bressler, GG Kaplan*.

Hospitalization for nephrolithiasis among inflammatory bowel disease patients: a common

extra-intestinal manifestation with inadequate prophylaxis. Can J Gastroenterol. 2012; 26

(SA): A093.

76. H Kareemi, S Coward, M Proulx, D Tanyingoh, S Quan, A Frolkis, E Dixon, R Myers, A

MacLean, S Brar, GG Kaplan*. Comparing the incidence of perforated and non-perforated

appendicitis: a validation and temporal trend study. Can J Gastroenterol. 2012; 26 (SA):

A212.

77. Kevans, M Silverberg, W Xu, A Paterson, P Beck, C Bernstein, A Bitton, L Dieleman, B

Feagan, A Griffiths, H Huynh, K Jacobson, GG Kaplan, D Krause, K Madsen, J Marshall, P

Moayyedi, R Panaccione, M Ropeleski, E Seidman, K Siminovitch, D Snider, A Stadnyk, H

Steinhart, D Turner, B Vallance, T Walters, K Croitoru. Increased frequency of risk alleles in

a cohort of healthy first-degree relatives of crohn's disease patients: A report of the CCFC

Michael J Howarth GEM project. Can J Gastroenterol. 2012; 26 (SA): A008.

78. A Rezaie, R Panaccione, R Fedorak, E Cheng, L Dieleman, S Ghosh, H Barkema, GG

Kaplan*. Time trends in prevalence and incidence of inflammatory bowel disease in

Alberta: A population-based study. Can J Gastroenterol. 2012; 26 (SA): A133.

79. Alexandra Frolkis, James Hubbard, Jennifer DeBruyn, Nathalie Jette, Cynthia Seow, Subrata

Ghosh, Remo Panaccione, Gilaad G Kaplan*. Effect of rural living on the odds of

inflammatory bowel diseases development: a nested case-control study. Am J Gastroenterol.

2011; 106 (S2): S474.

80. Gilaad G. Kaplan*, Shanika De Silva, Christopher Ma, James N. Hubbard, Marie-Claude

Proulx, Subrata Ghosh, and Remo Panaccione. Decreasing Colectomy Rates for Ulcerative

Colitis Patients Following Increased Utilization of Immunomodulators and Biologics: A

Population-Based Time Trend Study. Gastroenterol. 2011; 140; 5 (Suppl 1): S267.

81. Allen Lim, Marie-Claude Proulx, James N. Hubbard, Shanika De Silva, Remo Panaccione,

Shane M. Devlin, Cynthia H. Seow, Yvette Leung, Subrata Ghosh, Gilaad G. Kaplan*.

Venous Thromboembolism in the Hospitalized Ulcerative Colitis Patient. Gastroenterol.

2011; 140; 5 (Suppl 1): S428.

82. Kerri L. Novak, Gilaad G. Kaplan, Remo Panaccione, Subrata Ghosh, Cynthia H. Seow,

and Stephanie Wilson. Establishing Normal Parameters of the Small and Large Bowel With

Transabominal Ultrasound: A Retrospective Study Comparing Patients With and Without

Inflammatory Bowel Disease. Gastroenterol. 2011; 140; 5 (Suppl 1): S764.

83. Aito Ueno, Suzanne Traves, Humberto Jijon, Yasmeen Khalil, Ida Rabbani, Simon A.

Hirota, Gilaad G. Kaplan, Herman Barkema, Paul L. Beck, Remo Panaccione, David Proud,

and Subrata Ghosh. The in-Vitro Effect of Cigarette Smoke Extract on Monocyte-Derived


39

Dendritic Cell Phenotypes is Different in Crohn's Disease Compared With Ulcerative Colitis

Patients. Gastroenterol. 2011; 140; 5 (Suppl 1): S495.

84. Samuel Quan, Natalie A. Molodecky, Alexandra Frolkis, Marie-Claude Proulx, Eddy Lang,

Robert P. Myers, Martin Storr, and Gilaad G. Kaplan*. Hospitalizations for Upper

Gastrointestinal Bleeding Secondary to Peptic Ulcer Disease: A Population-Based Validation

and Epidemiological Study. Gastroenterol. 2011; 140; 5 (Suppl 1): S730.

85. Rahim Kachra, Murad Bandali, Marie-Claude Proulx, Allen Lim, James N. Hubbard, Remo

Panaccione, Subrata Ghosh, and Gilaad G. Kaplan*. Long-Term Complications

Responsible for Hospital Readmission Following a Colectomy for Ulcerative Colitis: A

Population-Based Analysis. Gastroenterol. 2011; 140; 5 (Suppl 1): S770.

86. Matthew D. Sadler, James N. Hubbard, Subrata Ghosh, Paul L. Beck, Chris Prusinkiewicz,

and Gilaad G. Kaplan*. Predictors of Mortality Among Patients Admitted to Hospital for

Ischemic Colitis: A Population-Based U.S. Study. Gastroenterol. 2011; 140; 5 (Suppl 1):

S61.

87. Lisa Kish, Naomi Hotte, Edwin Cheng, Kevin P. Rioux, Gilaad G. Kaplan, Renaud

Vincent, Martin Storr, and Karen Madsen. Orally Ingested Urban Particulate Matter Induces

a PRO-Inflammatory Response and Decreases Microflora Diversity. Gastroenterol. 2011;

140; 5 (Suppl 1): S46-S47.

88. I Soon, B Kaplan, M Proulx, I Wrobel, J deBruyn, and GG Kaplan*. Post-Operative

Complications Following Colectomy For Ulcerative Colitis In Children: A Population-Based

Study. Can J Gastroenterol. 2011; 25 (SA): A112.

89. S Cerquozzi, M Proulx, C Ma, J Hubbard, W Ghali, and GG Kaplan*. The Role of

Preoperative Internal Medicine Consultations For Ulcerative Colitis Patients Undergoing

Colectomies. Can J Gastroenterol. 2011; 25 (SA): A133.

90. Negrón M.E, Barkema H.W., Rioux K. De Buck J., Checkley S., Beck P.L., Pannacione R.,

Dieleman, L.A., Proulx M.C., Kaplan G.G. Clostridium difficile infection in ulcerative

colitis: increased risk of colectomy and postoperative infectious complications. Am J

Gastroenterol 2011; 106 (S2): S481.

91. Ferris M, Kaplan B, Soon IS, Molodecky N, Dixon E, Benchimol E and Kaplan GG*. The

dynamic global incidence of acute appendicitis: a systematic review of international temporal

trends. Am J Gastroenterol. 2010 Oct;105 Suppl 1: S88.

92. Molodecky N, Soon IS, Rabi D, Ghali W, Benchimol E, Panaccione R, Ghosh S, and Kaplan

GG*. The incidence of IBD across time and geography: a systematic review. Am J

Gastroenterol. 2010; 105: S464, A1264.


40

93. Soon IS, Molodecky N, Rabi D, Ghali W, and Kaplan GG*. The relationship between urban

environment and IBD: a systematic review and meta-analysis. Am J Gastroenterol. 2010;

105: S465, A1265.

94. Ma C, Crespin M, Proulx MC, DeSilva S, Hubbard J, Prusinkiewicz M, Panaccione R, Ghosh

S, Myers R, and Kaplan GG*. Accuracy of administrative data in identifying ulcerative

colitis patients presenting with acute flare and undergoing colectomy. Am J Gastroenterol.

2010; 105: S467, A1270. 2010 Presidential Poster.

95. A. Cheifetz, G. Melmed, B. Spiegel, J. Talley, S. Devlin, L. Harrell, P. Irving, J. Jones, G.G.

Kaplan, P. Kozuch, M. Sparrow, F.S. Velayos, L. Baidoo, B. Bressler, C. Siegel. Setting

priorities for comparative effectiveness research in inflammatory bowel disease: results of an

international provider survey, expert rand panel, and patient focus groups. Am J

Gastroenterol. 2010; 105: S465, A1265.

96. Kaplan GG*, Hubbard JN, Korzenik J, Sands BE, Panaccione R, Ghosh S, Wheeler AJ, and

Villeneuve P. The Inflammatory Bowel Diseases and Ambient Air Pollution: A Novel

Association. Gut and Endoscopy. 2009: Abstract.

97. DeSilva S, Crespin M, Ma C, Prusinkiewicz M, Panaccione R, Ghosh S, MacLean A, Buie D,

Devlin S, Seow C, Leung Y, Hubbard J, and Kaplan GG*. Predictors of complications

following a colectomy for ulcerative colitis patients: a population-based study. Gut and

Endoscopy. 2009: Abstract.

98. Shaheen AA, Kaplan GG, Hubbard JN, and Myers RP. The impact of waiting for emergent

endoscopic procedures on mortality and resource utilization in patients with gastrointestinal

disorders. Gastrointestinal Endoscopy 2009; 69(5 Suppl): AB211.

99. Kaplan GG*, Rowe BH, Storr M, and Szyszkowicz M. Air pollution and non-specific

abdominal pain: A novel association. Gastroenterol. 2009; 136(5): P137.

100. Shaheen AA, Kaplan GG, Myers RP. Weekend Versus Weekday Admission and

Mortality from Esophageal Variceal Bleeding. Hepatology. 2008; 48(4 Suppl): 630A

101. Kaplan GG*, Dixon E, Panaccione R, Fong A, Chen L, Szyszkowicz M, Wheeler A,

MacLean A, Buie D, Leung T, and Villeneuve P. Air Pollution and Appendicitis: A Novel

Association. Am J Gastroenterol. 2008; 103 (s1): P820.

102. Kaplan GG*, Panaccione P, Hubbard J, Nguyen GC, Shaheen AM, Ma C, Devlin SM, &

Myers RP. IBD Patients Who Leave Against Medical Advice: Predictors and Temporal

Trends. Am J Gastroenterol. 2008; 103 (s1): P286.

103. Kaplan GG*, Hubbard J, Panaccione R, Shaheen AM, Nguyen GC, Devlin SM, and

Myers RP. Predicting Mortality from Comorbidity Indices in Administrative Databases

among Inflammatory Bowel Disease Patients. Am J Gastroenterol. 2008; 103 (s1): P285.


41

104. Ma C, Panaccione J, Heitman S, Devlin S, Ghosh S, and Kaplan GG*. Short and long-

term efficacy of adalimumab following infliximab non-response: A systematic review and

meta-analysis. Am J Gastroenterol. 2008; 103 (s1): P678.

105. Myers RP, Shaheen AA, Kaplan GG. Weekend versus weekday admission and mortality

from gastrointestinal hemorrhage due to peptic ulcer disease. Am J Gastroenterol. 2008; 103

(s1): P58.

106. Shaheen AA, Kaplan GG, Myers RP. Morbidity and mortality following coronary artery

bypass graft (CABG) surgery in patients with cirrhosis: A population-based study. J Hepatol

2008; 48(Suppl 2):S39.

107. R Parab, GG Kaplan, TA Griffiths, JD Butzner, I Wrobel, and KP Rioux. A study of

incidence rate and spatial distribution of pediatric IBD in Calgary. Can J Gastroenterol.

2008; 22 (Suppl A): 165A.

108. Jones J, Kenyon C, Devlin S, Panaccione R, Kaplan GG, and Quan H. The

epidemiology of inflammatory bowel disease in the Calgary Health Region: Application of a

New Administrative Definition. Can J Gastroenterol. 2008; 22 (Suppl A): 85A.

109. Chami G, Wilson S, Kaplan GG, Panaccione R. High resolution abdominal

ultrasonography in Crohn’s disease: Degree of correlation with endoscopic findings at the

terminal ileum. Can J Gastroenterol. 2008; 22 (Suppl A): 94A.

110. Abdel Aziz M. Shaheen, GG Kaplan, Robert P. Myers. Morbidity and Mortality

following coronary artery bypass graft surgery in patients with cirrhosis: An analysis of U.S.

Hospitalizations from 1998 to 2004. Can J Gastroenterol. 2008; 22 (Suppl A): 164A.

111. Williams C, Dupre M, Kaplan GG, Andrews CN, Shaffer E, Beck PL. Rising incidence

of eosinophilic esophagitis in the Calgary Health Region: A population based study.

Gastroenterololgy. 2008; 134 (4 Suppl 1): A291.

112. Heitman SJ, Manns BJ, Pontifex D, Hershfield NB, Kaplan GG, and Hilsden RJ. Initial

diagnostic yield of wireless capsule endoscopy in a randomized controlled trial of wireless

capsule endoscopy versus standard of care for obscure-overt gastrointestinal bleeding.

Gastroenterololgy. 2008; 134 (4 Suppl 1): A340.

113. L Meddings, RP Myers, AA Shaheen, KB Laupland, J Hubbard, & GG Kaplan*.

Predictors of Mortality Due to Pyogenic Liver Abscesses: An Analysis of US

Hospitalizations from 1998 to 2004. Gastroenterololgy. 2008; 134 (4 Suppl 1): A412.

114. S Asfaha, M Geddes, Y Leung, J Storek, S Devlin, J Jones, GG Kaplan, PL Beck, R

Panaccione. Risk Aversion profile of Crohn’s patients in Calgary: A feasibility study for

stem cell transplantation. Gastroenterololgy. 2008; 134 (4 Suppl 1): A496.


42

115. Myers RP, Papay KD, Shaheen AA, Kaplan GG. The relationship between hospital

volume and outcomes of esophageal variceal bleeding. Gastroenterololgy. 2008; 134 (4

Suppl 1): A.

116. Williams C, Dupre M, Kaplan GG, Andrews CN, Shaffer E, Beck PL. Risk of

endoscopic complications in patients with eosinophilic esophagitis. Can J Gastroenterol.

2008; 22 (Suppl A): 159A

117. Kaplan GG, Mcarthy E, Ayanian J, Korzenik J, Hodin R, Sands BE. Predictors of in-

hospital mortality following colectomy in ulcerative colitis patients: a nationwide population-

based analysis in the USA. Gastroenterology. 2007; 132(4 Supp S4): A654.

118. Kaplan GG, Seminowich S, Williams J, Muruve D, Dupre M, Urbanski SJ, Yilmaz S,

Burak KW, Beck PL. The Risk of Microscopic Colitis in Solid Organ Transplantation

Patients: A Population Based Study. Gastroenterology. 2007; 132(4 Supp S4): A342.

119. Jackson TD, Kaplan GG, Arena G, Page J, Rogers SO. Laparoscopic versus open

resection for colorectal cancer: a meta-analysis of oncologic outcomes. J Surg Res. 2007;

137(2):248.

120. Kaplan GG, Pedersen BV, Andersson RE, Sands BE, Korzenik J, Frisch M. The risk of

developing Crohn’s disease after an appendectomy: a population-based cohort study in

Swededn and Denmark. Can J Gastroenterol. 2007; 21(Suppl A).

121. Kaplan GG, Bressler B, Jackson T, Sands BE, Frisch M, and Korzenik J. The risk of

developing Crohn’s disease after an appendectomy: A Meta-analysis of observational

studies. Am J Gastroenterol. 2006; 101(9): S423.

122. Kaplan GG, Heitman S, Hilsden R, Urbanski S, Myers R, Lee SS, and Panaccione R. A

population-based assessment of the surveillance practice of colonic dysplasia in primary

sclerosing cholangitis. Gastroenterol. 2006; 130(4 Suppl 2): A652.

123. Yan B, Kaplan GG, S Urbanski, and PL Beck. Population-Based Study of the

epidemiology of gastrointestinal stromal tumors. Gastroenterol. 2006; 130(4 Suppl 2): A421.

124. Kaplan GG, Heitman S, S Urbanski, SS Lee and R Panaccione. Screening for dysplasia

in primary sclerosing cholangitis - A population-based assessment of physician practices. Am

J Gastroenterol. 2005; 100(9): S314.

125. Willams J, Kaplan GG, S Urbanski, and PL Beck. Population-Based Study of the

epidemiology of microscopic colitis. Can J Gastroenterol. 2005; 19(Suppl B): 8.

126. Kaplan GG, KB Laupland, D Butzner, S Urbanski, and SS Lee. Population-Based Study

of the Incidence of and the Risk Factors for Primary Sclerosing Cholangitis. Gastroenterol.

2005; 128 (4 Suppl 2): A773.


43

127. Kaplan GG, Bates D, McDonald D, Romagnuolo J. Institutional interventions

significantly reduce IV pantoprazole prescribing errors. Gastroenterol. 2004; 126(4 Suppl 2):

A433.

128. Kaplan GG, Gregson D, Laupland K. Population-based study of the epidemiology of

and the risk factors for pyogenic liver abscess. Gastroenterology. 2004; 126(4 Suppl 2):

A716.

129. Kaplan GG, Bates D, Romagnuolo J. Inappropriate use of intravenous proton pump

inhibitors: Problem extent and cost implications. Am J Gastroenterol. 2002; 97(9): S236.

130. Kaplan GG & Mellor J. Differences in physical findings of the chest between young and

elderly healthy adults. Clinical Investigative Medicine. 1999; 22(4):S51.

131. Der Siaphet T, Kaplan GG, Browne A, Malysz J and Huzinga J. Innervation to the small

intestine in +/+ and W/WV mice. Digestive Diseases and Sciences. 1996; 41(9):1890.

O’Brien of Crohn’s and Colitis Canada · 2016-02-01 · Curriculum Vitae Gilaad G. Kaplan, MD,...

Documents

Transcript of O’Brien of Crohn’s and Colitis Canada · 2016-02-01 · Curriculum Vitae Gilaad G. Kaplan, MD,...